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CHAPTER 1 
Introduction and Literature Review 
1.1 Introduction 
Atrial fibrillation (AF) is the most common cardiac arrhythmia, 
affecting 1% of the general population, 6% of people over the age 
of 65, and 9% of people over the age of 80.1, 2 With a squaring of 
the population age distribution, the overall prevalence of AF and 
its impact on the health system is set to increase.3, 4  
AF is associated with considerable morbidity and mortality. 
Specifically, AF is an independent risk factor for stroke, occurring 
in up to 19% of stroke patients over the age of 70.5 Furthermore, 
AF is associated with a 1.5 to 1.9 fold increased risk in all-cause 
mortality.6  
The effectiveness of medical therapy targeting rate and/or rhythm 
control and stroke risk reduction is modest at best and not without 
side effects. In particular, warfarin anti-coagulant therapy reduces 
the relative risk of stroke by only 70%. Furthermore, the risk of 
major bleeding with warfarin use is 0.5%-1% per annum and in 
2 
 
those over the age of 80, this risk can rise to as high as 13% in 
the first year.7 
Short of open heart surgery, the only alternative to current medical 
therapy is percutaneous catheter-based radiofrequency ablation 
which results in electrical isolation of the pulmonary veins. 
Pulmonary vein isolations are successful in eradicating AF in 
~50% of cases. Often, patients must endure up to 3 separate 
ablation sittings before a 70% success rate is achieved. The risk 
of ablation procedures is considerable with a 6% rate of major 
complications that include cardiac tamponade, pulmonary vein 
stenosis, arteriovenous fistulas, thromboembolism, need for open 
heart surgery, and death.8 
Clearly with an aging population and the sub-optimal treatment 
options currently available, there is a desperate need for a greater 
understanding of the disease process. 
Over the last 2 decades, there has been mounting evidence that 
connexins play a significant role in cardiac myocyte electrical 
coupling. In particular, alterations in levels and patterns of 
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connexin expression in humans have been purported to facilitate 
the substrate required for the chronic form of AF.9 
More recently, one germline and three somatic mutations of the 
gene encoding the gap junction protein connexin40 (Cx40) in 
patients suffering from idiopathic AF were identified by Gollob et 
al. and published in the New England Journal of Medicine.10 Since 
this first discovery, Gollob’s lab has identified a further somatic 
mutation, this time in connexin43 (Cx43), in a patient with lone 
AF.11 One of the major limitations of these disease-causing gene 
discoveries is the lack of a convincing, demonstrable, functional 
effect on electrical cardiac conduction that could underpin the 
generation of AF. 
The following section will assess peer-reviewed literature on Cx40 
and Cx43, with a particular focus on their functional roles in 
cardiac conduction. With a greater understanding of the 
consistencies and inconsistencies of the literature, the subsequent 
in vitro and in vivo research will aim to assess the functional 
effects of the above mentioned Cx40 mutations, in particular 
focusing on their propensity to cause AF. 
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1.2 Literature Review 
1.2.1 Connexins and gap junctions 
Gap Junction Structure 
Connexins are a family of phosphoproteins consisting of 4 
hydrophobic trans-membrane α-helices joined by 2 extracellular 
loops and 1 intracellular loop, and a hydrophilic cytoplasmic 
carboxy-terminal tail as shown in Figure 1.1.12 Approximately 21 
different connexin isotypes have been identified.13 The trans-
membrane α-helices are relatively conserved between isotypes, 
while the connecting loops and tail vary widely, hence determining 
isotype specific properties.14 
Connexins group together in hexamers to form trans-membrane 
hemi-channels termed connexons as shown in Figure 1.2A. In 
cardiac myocytes, connexons actively coalesce within the 
intercalated disks at sites of cadherin mediated cell-cell adhesion 
called gap junctions. Here, the extracellular faces of connexons 
dock with each other in a one to one fashion between adjacent 
cells forming inter-cellular communications through a central 
aqueous pore as shown in Figure 1.2B.14 Once formed,  
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Figure 1.1 Connexin structure 
A connexin (pink) consists of 4 trans-membrane α-helices (M1, 
M2, M3, M4) linked together by 2 extracellular loops (EL1, EL2) 
and 1 cytoplasmic loop (CL). Both the N terminus and C terminus 
have an intracellular location.  
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Figure 1.2 Gap junction structure 
A) A connexon consisting of 6 trans-membrane connexins. B) Two 
cell membranes connected by docked connexons with a central 
aqueous pore (dotted arrow). Connexons can vary in the 
proportion and distribution of their constituent connexin isotypes 
(green and pink). 
A 
 
B
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connexons have a relatively short half-life, being internalised and 
degraded after 1 to 5 hours.15-17    
Connexon hemi-channels can be either homomeric, being formed 
from only one connexin isotype, or heteromeric, being formed 
from multiple connexin isotypes. Coupled connexons can be 
homotypic, containing the same connexins, or heterotypic, 
containing different connexins as shown in Figure 1.2B.14  
A connexons’ isotype content, degree of phosphorylation, and 
location, determines its functional capacity for intercellular passive 
ion transfer.14 
Gap Junction Conductance 
Action potential propagation in cardiac myocytes is dependent on 
the extracellular and intra cellular passive transfer of ions across 
an action potential wavefront between depolarised and polarised 
zones as shown in Figure 1.3. Transfer of ions allows the resting 
membrane potential to be depolarised to the thresholds required 
for membrane ion channel activation of action potentials.18 
8 
 
Propagation velocity is determined by the rate of passive transfer 
of ions between both zones. This in turn is determined by drivers 
of passive ion transfer and resistors to this process. The main 
drivers are action potential amplitude and speed of action 
potential generation. The main resistors are intra-cellular 
cytoplasmic resistance and inter-cellular gap junction coupled 
connexon resistance. The resistance of the central aqueous pore 
of cell-cell coupled connexons is inversely proportional to its 
conductance capacity.18 
Pioneering dual whole cell voltage clamping in the study of gap 
junctions, Neyton et al first quantified junctional conductance and 
average unitary conductance’s of constituent channels in rat 
lacrimal gland cells. The study demonstrated the presence of 
variable channel conductance during voltage gating with an 
average unitary conductance in the fully open state of 120pS.19 
Using a similar method to Neyton et al, Veenstra et al 
demonstrated an average channel unitary conductance of 164 ± 
26pS in embryonic chicken ventricular myocytes, while Burt et al 
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obtained a clearly different average unitary conductance of 50 ± 
2pS in neonatal rat ventricular myocytes.20, 21 These early studies 
however, did not consider the effects of differing patterns of 
connexin isotype expression between cell types. 
Following the identification of multiple connexin isotypes, dual 
whole cell voltage clamping studies revealed conductance 
differences between homomeric homotypic channels consisting of 
either connexin40 (Cx40) or connexin43 (Cx43). In HeLa cells, 
Cx40 channels were associated with a larger average unitary 
conductance of 121pS to 153pS compared to the 40pS to 60pS of 
Cx43 channels.22 
When the voltage applied across a uniform channel is changed 
slowly from positive to negative, a slow symmetrical change in the 
absolute amplitude of ion conductance from one direction to the 
other is often observed and is referred to symmetrical voltage 
gating. When a channel’s structure is asymmetric from end to end, 
then different directional amplitudes of ion conductance between 
similar positive and negative voltages are observed, a 
phenomenon referred to as asymmetrical voltage gating.   
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Valiunas et al observed a similar pattern of average unitary 
conductance’s to that identified in previous studies with levels of 
135pS and 76pS for junctions composed of either Cx40 or Cx43 
respectively, when expressed in connexin-null HeLa cells. 
Macroscopic junctional conductance sensitivities to voltage gating 
in these channels were symmetrical. Homomeric heterotypic Cx40 
and Cx43 channels however demonstrated both asymmetrical 
unitary conductance’s (~60/100pS) and asymmetrical voltage 
gating sensitivities. In addition, in HeLa cells, when compared to 
junctions composed of either Cx40 or Cx43 homomeric homotypic 
channels, gap junctions consisting of channels homomeric and 
heterotypic for connexins 40 and 43 demonstrated markedly 
reduced total conductances of 73% and 68% respectively.23 
Cottrell and co-workers further demonstrated that connexins 40 
and 43 were capable of forming a wide variety of 
heteromeric/heterotypic channels when studied in Rin and A7r5 
cells. Channel unitary conductances varied widely and were 
predominately lower than those of channels homomeric and 
homotypic for Cx40 (<120pS). Heteromeric/heterotypic channels 
higher in Cx43 content frequently possessed conductances lower 
than 60pS. Altered asymmetrical junctional voltage gating 
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sensitivities were also observed when compared to 
homomeric/heterotypic Cx40 and Cx43 channels.24 A second 
study by the group involved altering the ratio of Cx40 to Cx43 in 
A7r5 cells from a baseline of 2.7:1 to 5.3:1 and 10.6:1 using Cx40 
transfection. When these three groups of A7r5 cells were coupled 
to Rin43 cells, an increase in the Cx40:Cx43 ratio was associated 
with a non-linear reduction in unitary conductances to below that 
of Rin43/Rin43 coupled cells. When the three A7r5 groups were 
coupled to Rin40 cells, there was a small non-linear reduction in 
unitary conductances to below that of Rin40/Rin40 coupled cells. 
The results suggest a J shaped drop in conductance from that of 
Cx40 only channels to Cx43 channels as the ratio of Cx40 to 
Cx43 drops in a connexon. Unfortunately, a similar experiment 
using Cx43 transfected A7r5 cells was not performed.25  
More recently, Gollob et al demonstrated the effects of Cx40 
missense mutations, identified in patients with idiopathic atrial 
fibrillation (AF), on gap junction conductance. Dual whole cell 
voltage clamping of transfected N2A cells revealed almost 
complete abolishment of channel activity with P88S, A96S, and 
G38A mutants. Immunofluorescence in each case revealed an 
altered pattern of gap junction expression with intracellular 
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accumulation of mutant connexins. When either P88S or A96S 
mutants were co-transfected with only wild-type Cx40 or wild-type 
Cx40 and Cx43 in xenopus oocytes, junctional conductance fell to 
well below that of their wild-type connexin only controls 
respectively. The results suggested that mutations in Cx40 could 
exert a dominant negative effect on gap junction conductance. 
Importantly the cellular pattern of expression of wild type Cx43 
and Cx40 in oocytes was not assessed to exclude a cellular 
manufacturing/transport problem. This was particularly important 
given that an altered pattern of mutant Cx40 expression had been 
identified in N2A cells with immunofluorescence. 
Gollobs lab went on to study the gap junctional effects of a 
somatic Cx43 frame-shift (932delC) mutation that was identified in 
a patient with lone AF. Coupled 932delC transfected N2A cells 
revealed a marked reduction in junctional conductance when 
compared to wild-type Cx43 transfected controls. Furthermore, 
when compared to wild-type Cx43 only junctions, there was a 
dominant negative effect on junctional conductance when 
932delC was co-transfected with either wild-type Cx43 or wild-
type Cx40. Results of studies repeated in xenopus oocytes were 
similar to the N2A studies except in the setting of 932delC and 
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Cx40 co-transfection, where there was a failure to exhibit a 
dominant negative effect on conductance. Co-transfection with 
932delC, wild-type Cx43, and wild-type Cx40 resulted in a small 
but significant reduction in junctional conductance compared to 
wild-type only connexin co-transfection. Immunofluorescence in 
HeLa cells transfected with 932delC revealed only sparse gap 
junction formation with intracellular retention within the Golgi 
apparatus. This was in contrast to HeLa cells transfected with 
wild-type Cx43 only, which formed numerous gap junctions with 
co-localization. When 932delC was co-transfected with either wild-
type Cx43 or Cx40 into HeLa cells, a dominant negative effect on 
wild-type connexin expression was observed with sparse gap 
junction formation and intracellular accumulation. This again was 
in contrast to HeLa cells co-transfected with wild-type Cx43 and 
Cx40, which formed numerous gap junctions with co-localization. 
The dominant negative effect on expression of both wild-type 
connexins was also observed in sections of atrial tissue using a 
diaminobenzidine (DAB) chromagen system. Importantly however, 
immunofluorescence was not performed within N2A cells and 
oocytes to elucidate the differences in conductance results 
observed between both cells types.11   
15 
 
While gap junctions clearly have varying conductance's and 
hence likely varying effects on tissue conduction velocities, 
directional asymmetry of voltage gating sensitivities and mutations 
may further increase the arrhythmogenic potential of cardiac 
tissue. The proportional content of connexin isotypes and mutants 
in gap junction channels and the cellular mechanisms involved in 
controlling proportions during normal physiology and disease 
states however, have yet to be determined.  
Connexins and Cardiac Distribution 
Connexin isotype expression varies between the different 
chambers and structures of the heart as shown in Figure 1.4. 
Hence the role of connexin isotype expression at various areas of 
the heart is best appreciated by the functional conduction 
velocities at those areas.  Of note, Davis et al demonstrated in 
humans that cells of the bundle branches, the fastest conducting 
cells of the heart, contained the largest gap junctions with 
abundant levels of connexins 40, 43, and 45. In contrast, the sino-
atrial and atrioventricular nodal cells had the smallest gap 
junctions. Cells from both nodes expressed small levels of 
connexins 45 and 40, and atrioventricular nodal cells also 
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expressed Cx43. Atrial and ventricular myocytes contained 
moderate sized gap junctions. Atrial myocytes expressed 
moderate amounts of connexins 40, 43, and 45, while ventricular 
myocytes expressed only connexins 43 and 45.26 
It should be noted that there is also variation of connexin isotype 
expression in the same areas between mammalian species. The 
results are best demonstrated by the differences in Cx40 
distribution between guinea pig and rat hearts. Gros et al 
demonstrated in guinea pigs that Cx40 was only expressed within 
atrial myocytes, being absent from the ventricles and conducting 
system. In contrast, rats expressed Cx40 only within the His-
Purkinje/bundle branch system. Both species clearly had a Cx40 
expression profile that was also different to that of humans.26, 27 
Tissue Anisotropy 
Anisotropic tissue conduction refers to the directional dependence 
of conduction velocity imparted by tissue structure. Hence when 
conduction velocity in one direction (such as parallel to fibre 
orientation) is different to another direction (such as perpendicular 
to fibre orientation), anisotropic conduction is said to exist. The 
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Figure 1.4 Human cardiac connexin isotype distributions.  
The pattern of connexin isotype distribution within the human 
heart is illustrated below. The size of text (large, medium, small, 
very small) indicates the relative amount (abundant, moderate, 
little, minute) of each connexin isotype within various structures of 
the heart. (SA – sinoatrial; AV – atrioventricular) 
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greater this difference, the greater the degree of anisotropy.28 The 
factors determining the degree of conduction anisotropy within 
tissue include myocyte morphology and coupling patterns, and the 
subcellular pattern of gap junction and sodium channel 
expression.29 Differing tissue conduction anisotropy has been 
noted between atria and ventricles, and during specific disease 
states.  
Saffitz and co-workers demonstrated differing patterns of tissue 
anisotropy between the crista terminalis and ventricles in adult 
canine hearts. Tissues obtained were studied using light and 
electron microscopy, Northern blotting, and 
immunohistochemistry. Individual ventricular myocytes were found 
to couple to approximately 11 other myocytes on average. When 
compared to ventricular myocytes, individual myocytes within the 
crista terminalis coupled to approximately 43% fewer myocytes, 
with more coupling in a predominantly end-to-end rather than 
side-to-side pattern (77% versus 53%). In addition, the crista 
terminalis possessed predominately small discoid gap junctions 
aligned in rather straight intercalated discs at their true ends. In 
contrast, ventricular myocytes possessed both small discoid gap 
junctions at the plicate segments of the intercalated discs, and 
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larger ribbon-shaped junctions with long axes oriented 
perpendicular to the cellular long axis and located in the inter-
plicate regions. Hence the highly anisotropic arrangement of the 
crista terminalis likely contributes to the characteristic directional 
differences of conduction velocity compared to the ventricles, with 
minimal conduction in the transverse direction (longitudinal to 
transverse conduction velocity ratio of ~10 versus ~3 
respectively).30, 31 
Luke and co-workers hypothesised that the slow propagation, 
conduction block, and fractionated electrograms identified in 
canine infarct models of arrhythmia were due to altered myocyte 
interconnections. Light and electron microscopy were used to 
identify an increase in intercellular collagen, reduction in large gap 
junctions located in the inter-plicate regions of the intercalated 
disks, and a reduction in the number of myocytes that an 
individual myocyte coupled with, this being more so with cells that 
were predominantly positioned side-to-side. As a result a 
transversely directed wavefront would encounter greater 
resistance to conduction and path length.32 
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Peters et al demonstrated the ability of tissue anisotropy to result 
in arrhythmia following myocardial infarction. A total of 6 dogs 
received LAD infarctions and only 3 were subsequently 
susceptible to inducible ventricular tachycardia (VT). Figure-of-
eight re-entry was observed during each VT episode and occurred 
over the thinnest area of viable myocardium. 
Immunohistochemistry revealed that the lateral walls of the central 
common pathway consisted of myocytes with reduced intercalated 
disc content of Cx43, a finding consistent with the reduced 
number of gap junctions observed by Luke et al. The roof and 
floor of the central common pathway were formed by the 
epicardium and non-viable myocardium respectively. An increase 
in lateralised membranous Cx43 expression in myocytes was 
noted but its functionality was not investigated.33 
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1.2.2 Connexins, Conduction, and Arrhythmia 
Based on the tissue specific distribution of connexin isotypes and 
their properties in gap junctions, alteration of location specific 
conduction velocities might be expected as individual isotype 
expression is altered. 
The results of investigations however, into the role connexins play 
in electrical propagation and arrhythmia in the heart, have been 
inconsistent. Two main techniques have been used by 
investigators to assess these roles. The first has involved the 
knockout of connexin expression with subsequent assessment of 
conduction. Outcomes assessed have included measures 
representative of conduction velocity acquired through cutaneous 
electrocardiograms and functional electrophysiological studies, 
and tissue conduction velocity itself via surface electrode arrays 
and optical mapping systems. Interpretation of the results of 
genetically engineered animal studies is however hampered by 
the high rate of congenital malformations associated with 
connexin knockout.34-36 The second technique involves the study 
of differences in connexin expression between sinus rhythm and 
an arrhythmia such as AF, with subsequent correlation of 
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differences with conduction parameters. Interpretation of the 
results however must be made within the context of the method 
used to generate the arrhythmia, or the disease process setting in 
which the arrhythmia occurs. 
1.2.2.1 Genetically Engineered Mice Models 
Cutaneous Electrocardiographic Studies 
Simon et al examined the effects of alterations in Cx40 expression 
levels on the electrocardiogram (ECG) durations of P waves, PR 
intervals, and QRS complexes. Heterozygous and homozygous 
Cx40 knockout mice were bred through mating 129/Sv strains with 
C57BL/6 strains. Conventional three lead ECG’s were produced 
using limb needle electrodes during pentobarbital intra-peritoneal 
anaesthesia. The P, PR, and QRS intervals were similar between 
wild-type and heterozygous knockout mice. However there were 
significantly increased P wave durations of 13.4ms versus 
12.3ms, PR intervals of 41.2ms versus 34.1ms, and QRS 
durations of 15.5ms versus 11.6ms between homozygous 
knockout and wild-type mice respectively. No spontaneous 
arrhythmias were observed.37 Based on previously described 
patterns of cardiac tissue distribution of Cx40, it was suggested 
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that Cx40 was an important determinant of both atrial and His-
Purkinje conduction velocities.38 Closer examination of 
immunofluorescence images however reveals an absence of 
Cx40 expression within the atria of wild-type mice and hence 
would not explain the P wave prolongation that occurred in 
homozygous knockout mice. While ventricular chamber size was 
studied, no data was provided on atrial size. It is possible that 
homozygous knockout mice possessed developmentally related 
atrial dilation, a feature that would result in P wave prolongation.  
Using a similar method to Simon et al, both Kirchhoff et al and 
Hagenfdorff et al achieved similar patterns of alteration in ECG 
parameters with Cx40 knockout mice. However both groups noted 
more pronounced prolongation in P wave durations and also 
observed high frequency re-entrant atrial arrhythmias, intermittent 
sino-atrial block, and intermittent atrio-ventricular block in 
homozygous knockout mice. When compared to wild-type mice, P 
waves in homozygous knockout mice were prolonged by 57% and 
56% in their studies respectively. Of note, Kirchhoff et al 
demonstrated the presence of Cx40 in wild-type atria. Connexins 
43 and 45 were also demonstrated within the atria of null Cx40 
mice, however immunostaining within wild-type atria were not 
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performed to assess for possible changes in levels of expression. 
Both studies came from the same lab, using 129/Sv/C57BL/6 
mice and intra-peritoneal Avertin for anaesthesia.39, 40 Bearing in 
mind the genetically engineered nature of the mice used, the 
results suggested that reduced Cx40 expression could produce a 
suitable substrate to precipitate re-entry.34 The presence of sino-
atrial and atrio-ventricular block was unexpected but may have 
been due to altered coupling between the atria and these regions 
or altered levels of vagal tone under anaesthesia. 
P wave prolongation by 25% in addition to QRS widening was 
also observed by Verheule et al in 129/Sv/C57BL/6 Cx40 
homozygous knockout mice. The QRS widening was abolished 
when the ventricles were stimulated from the epicardial surface 
rather than being activated through the intrinsic His-Purkinje 
system, confirming that Cx40 participated in His-Purkinje 
conduction. No spontaneous atrial arrhythmias were observed, an 
absence of which may again have been due to less pronounced P 
wave prolongation in homozygous knockouts compared to 
Kirchhoff et al and Hagenfdorff et al. Surprisingly, PR intervals 
were not significantly prolonged in this study suggesting normal 
coupling of the atrioventricular node to surrounding structures. 
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Assessment of connexin expression was not made to elucidate 
this difference, and sample sizes were smaller compared to 
Kirchhoff et al. Mice in this study were anaesthetised with 
urethane.41 
Interestingly, Cx40 heterozygous knockout mice possessed ECG 
parameters similar to wild-type mice in the 4 above mentioned 
studies. Levels of connexin expression, both 40 and 43, in atria 
heterozygous for Cx40 were not assessed however.  
More recently, Bagwe et al demonstrated, using both 6 lead 
surface ECG’s in conscious mice and volume conducted ECG’s of 
Langendorff perfused hearts, prolongation of P wave, PR, and 
QRS durations in Cx40 homozygous knockout mice compared to 
wild-type mice. Aberrant P waves within all homozygous knockout 
mice were observed regardless of the method of ECG acquisition. 
The presence of aberrant P waves was suggestive of an atrial 
ectopic rhythm rather than sinus rhythm, and hence Cx40 was 
considered to be important in sinus node function as well.42 Cx43 
levels within whole hearts and atria were similar between both 
groups with Western blotting and immunofluorescence. 
Differences in ECG acquisition with fewer leads may have 
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accounted for the lack of observation of P wave aberrancy in the 
prior detailed ECG studies.  
Other potential confounding factors for result variances between 
the five studies included potential definition differences, the use of 
knockout mice, litter variances, and differing anaesthetic agents. 
Pentobarbital has been shown to alter conduction and 
automaticity in canine models while Avertin is a known cardio-
depressant in mice.43, 44 
Thomas et al demonstrated that reduced Cx43 expression within 
the atria of Cx43 heterozygous knockout mice did not result in 
atrial conduction slowing as evidenced by similar P wave 
durations to that of wild type mice. When compared to wild-type 
mice however, quantitative densitometry of immunoblots for atrial 
Cx43 revealed an approximately 60% reduction in expression. 
There were no significant alterations in Cx40 levels. These results 
suggested that Cx40 was the main determinant of conduction 
velocity within the atria. Conversely, reduced ventricular levels of 
Cx43 expression assessed by Western blotting were associated 
with slow ventricular conduction. In particular, heterozygous 
knockouts possessed 72% wider mean QRS intervals compared 
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to wild-type mice, indicating that Cx43 was the main determinant 
of conduction velocity within the ventricles. Genetically engineered 
mice were of C57BL/6 origin and studied under pentobarbital and 
ketamine anaesthesia.45 
It should be noted that Morley et al failed to identify a difference in 
mean QRS width between wild-type and Cx43 heterozygous 
knockout mice. Interval definitions used by Morley et al were 
similar to Kirchhoff and anaesthetised wild-type mice possessed 
similar QRS durations of 14.5ms and 17.1ms between both 
studies. Mice were anaesthetised with ketamine and 
acepromazine.46  
In an attempt to explain the findings of Morley et al, Eloff et al 
compared epicardial electrogram QRS complexes with optically 
recorded action potentials using mice hearts. While the onset of 
QRS complexes coincided with action potential onset, the timing 
of QRS offset was more difficult to discern with 
electrocardiography and may have explained the QRS width 
discrepancies between Thomas et al and Morley et al. The width 
of QRS complexes were not reported by Eloff et al however.47 
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Functional Electrophysiological Measurements 
Electrophysiological studies complement electrocardiograms, 
allowing assessment of electrical conduction, refractoriness, and 
arrhythmia vulnerability at specific locations within the heart. 
Assessment includes function of the sinus node, atrio-ventricular 
node, and His-Purkinje system through sinus node recovery 
times, AH intervals, and HV intervals respectively. Atrial and 
ventricular refractory periods can also be assessed.48 
In addition to electrogram studies, Hagendorff and co-workers 
performed limited electrophysiology studies via trans-oesophageal 
pacing and recording on Cx40 deficient and wild-type mice. Mean 
sinus node recovery times were 41% longer and both sinus node 
entry and exit block were observed in Cx40 deficient mice. 
Furthermore, significantly longer minimum 1:1 atrioventricular 
(AV) nodal conduction times of 13% were demonstrated in Cx40 
homozygous knockout mice. These findings provide further 
evidence that Cx40 is involved in the electrophysiology of the 
sinus and AV nodes. Without His electrograms it was not possible 
to determine if the His-Purkinje system was affected as well by 
Cx40 knockout. Increased propensity to arrhythmia, both 
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spontaneous and stimulated was demonstrated in Cx40 
homozygous knockout mice. Arrhythmias displayed features of 
either re-entry or AF.40 
Building on the results of Hagendorff et al, in vivo 
electrophysiological studies were also performed by Verheule et al 
in similar Cx40 deficient and wild-type mice. Measurements and 
stimuli were facilitated however, with 0.03mm fine wire epicardial 
surface electrodes placed via a thoracotomy. Similar to 
Hagendorff et al, corrected sinus node recovery times and AV 
Wenckebach times were prolonged in Cx40 homozygous 
knockout mice. Effective refractory periods of the atria and 
ventricles were similar between Cx40 homozygous knockout and 
wild-type mice. This time only induced re-entrant type arrhythmia 
was observed.41 
Thomas et al performed intra-cardiac electrophysiology studies 
(EPS) in Cx43 heterozygous knockout mice. Atrial effective 
refractory periods, sinus node recovery times, and AV 
Wenckebach times were similar to wild-type mice. There was a 
38% prolongation in the ventriculo-atrial Wenckebach time 
suggesting impaired 1:1 coupling between the ventricles and AV 
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node. Ventricular effective refractory periods were non-
significantly prolonged. Of note, small sample sizes were used 
and wide standard deviations observed. The results provided 
further evidence that the major determinant of electrophysiology of 
the atria was likely to be Cx40 and not Cx43.45 
Direct Conduction Velocity 
Consistent with electrogram studies and knowledge of Cx40 
tissue distribution, Verheule et al demonstrated 30% slower intra-
atrial and unaltered intra-ventricular conduction velocities during 
pacing at a cycle length of 100ms in Cx40 homozygous knockout 
mice compared to wild-type mice. In vivo measurements were 
made and stimuli delivered using a hand held probe consisting of 
2 stimulus electrodes at one end oriented perpendicular to a linear 
array of 4 unipolar electrodes. No details were provided regarding 
the method used for consistent probe orientation over each 
chamber.41 
Bagwe and co-workers further assessed, with optical mapping, 
the role of Cx40 on right atrial electrical excitation and conduction 
using Langendorff-perfused hearts from wild-type and Cx40 
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homozygous knockout mice. Perfusate containing Tyrodes 
solution and the voltage sensitive dye di-4-ANEPPS was 
maintained at 37-38°C. No mechanical or pharmacological motion 
reduction technique was used during the experimental protocol. 
Two Dalsa high resolution CCD cameras acquiring at 920 frames 
per second were used for recording. A translational motion 
tracking and correction algorithm based on a template matching 
technique was applied offline to eliminate mechanical errors. 
Optical mapping revealed that spontaneous beating originated 
from ectopic sites within the right atrium of knockout mice, a 
finding that explained the aberrant P wave morphologies observed 
on their ECG’s. In addition there was a shift towards 
heterogeneously slower conduction velocities with some areas of 
extremely delayed activation suggesting conduction block. 
Successive ablations of ectopic pacemaker sites until the sinus 
node was the leading pacemaker site revealed that the sinus node 
possessed a longer cycle length compared to wild-type mice. 
Atrial pacing at 10Hz revealed a uniform reduction in conduction 
velocity of approximately 36% across the atria of knockout mice, 
without evidence of conduction block. However as pacing 
frequency was increased up to 25Hz, increasing areas of 
conduction block became evident. This increasing inability to 
32 
 
maintain 1:1 conduction suggested a reduced safety factor for 
atrial conduction in Cx40 knockout mice, a substrate property 
postulated to allow for fibrillation of the atria.49 Microelectrode 
techniques excluded alterations in membrane properties as a 
cause for the observed results. In particular, there were no 
changes in resting membrane potential and action potential 
parameters including maximal dV/dT, amplitude, and duration.42 
Using high resolution optical mapping, Tamaddon et al extended 
the assessment of the effects of Cx40 homozygous knockout to 
the bundle branches of the ventricular conducting system. Results 
were compared to wild-type mice hearts. Langendorff perfused 
mice hearts were maintained without motion reduction techniques 
at 37°C to 38°C and perfused with Tyrodes solution. A Dalsa CCD 
camera was used, sampling at 912 frames per second with 12 bit 
resolution. During sinus rhythm and atrial pacing at cycle length of 
120 milliseconds, right ventricular activation was grossly delayed 
with only mildly delayed left ventricular activation in Cx40 
knockout hearts. Ventricular epicardial pacing revealed no 
differences in conduction velocities, indicating that the activation 
delays from atrial pacing were due to conduction slowing within 
the ventricular conduction system. Direct imaging of the right 
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bundle of the ventricular conduction system revealed conduction 
slowing within this branch. Comparisons of bundle activation times 
with volume conducted ECG’s revealed no significant conduction 
delay within the left bundle of knockout hearts. The results 
suggested that Cx40 was the main determinant of conduction 
within the right bundle of the ventricular conducting system, but 
not the left.50 
Guerrero et al studied the effect of reduced Cx43 on ventricular 
conduction velocity in neonatal and adult Cx43 heterozygous 
knockout mice hearts. Results were compared to wild-type hearts. 
Velocities were measured using an electrode array placed in a 
consistent manner on the epicardial surface parallel to the left 
anterior descending artery of superfused neonatal and perfused 
adult hearts that were cooled to 31°C and paced at 200 beats per 
minute. A temperature of 31°C was chosen to slow the 
spontaneous beat frequency of hearts enough to facilitate 
ventricular pacing. Spontaneous beat frequency was similar 
between Cx43 heterozygous knockout and wild-type hearts. The 
results of ventricular pacing revealed that Cx43 heterozygous 
knockout reduced conduction velocity by 30% and 44% in 
neonatal and adult hearts respectively. There was no difference in 
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ventricular effective refractory periods. Furthermore, assessment 
during spontaneous beating in neonatal hearts revealed no 
difference in AV conduction times between knockout and wild-type 
hearts. Histological analysis of adult mice hearts revealed no 
obvious difference in myocardial fibre orientation or curvature of 
the anterior left ventricular free wall between Cx43 knockout and 
wild-type groups. Furthermore fibres were parallel to the 
orientation of the recording array indicating that maximum 
conduction velocities were recorded. The results suggested that 
Cx43 was a major determinant of ventricular myocyte 
conduction.51 
Thomas et al also studied the effects of reduced Cx43 on atrial 
and ventricular conduction in adult mice heterozygous for Cx43. 
Epicardial surface recordings were performed with a linear array 
on superfused adult mice hearts cooled to 31°C and paced at 200 
beats per minute. Atrial assessment was performed on both 
isolated and intact atria. A recording electrode array was placed 
on the right atrial appendage longitudinal to its long axis, and a 
stimulating electrode was placed at the distal most tip of 
appendage. In both isolated and intact atria, no difference was 
identified between wild-type and Cx43 heterozygous knockout 
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mice. Ventricular assessment was performed in a similar way to 
Guerrero et al. A significant 38% reduction in ventricular 
conduction velocity was observed in heterozygous mice.45 
Using optical mapping, Morley et al failed to identify a difference in 
ventricular conduction velocities between wild-type and 
heterozygous Cx43 mice. Excised hearts were perfused as 
Langendorff preparations between 37°C and 39°C. Fluorescence 
associated with mechanical artefact was inhibited by adding 
diacetyl monoxamine to the perfusate. Conduction velocities were 
measured with the assistance of the voltage sensitive dye di-4-
ANEPPS, and recorded via a CCD video camera. Two CCD 
cameras were used during the study. One was a Dalsa camera 
with a frame rate of 1500 frames per second and the other was a 
Cohu camera with a frame rate of 240 frames per second (1000 
frames per second after implementation of a synchronous 
acquisition system). The inability of linear epicardial surface 
electrodes to sample more than one dimensional conduction, to 
detect breakthrough activation and wavefront collision, and its 
dependence on stimulation electrode positioning was used to 
account for the differences between this study and earlier 
epicardial electrode array studies.46 
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Eloff and co-workers repeated the work of Morley et al, but used 
mice of both congenic and mixed genetic origins to control for the 
possible developmental defects known to occur in Cx43 deficient 
mice.36 Similar Langendorff preparations were used with diacetyl 
monoxamine and di-4-ANEPPS. An optical mapping system with 
a higher temporal resolution, sampling at a rate of 3400 samples 
per second, and a higher voltage resolution by virtue of a 
photodiode optical mapping array was used. In addition, 
algorithms were used to eliminate virtual electrode effects and 
errors caused by sub-epicardial breakthrough. Subsequent action 
potentials recorded had a time course of membrane potential 
change comparable to action potentials recorded with 
microelectrodes by Zhou et al52. An approximately 25% reduction 
in conduction velocity was subsequently observed in mixed and 
congenic mice heterozygous for Cx43 compared to wild-type 
mice. Based on weight, no differences in tissue oedema were 
found in hearts used for this study. Using light microscopy, fibre 
orientation was similar between wild-type and genetically 
engineered mice. Lower voltage and temporal resolutions, and 
lack of compensation for the virtual electrode effect were 
postulated as the reason for the failure of Morley et al to detect a 
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difference in conduction velocities between wild-type and 
heterozygous Cx43 knockout mice.47 
To avoid the confounding effects of congenital cardiac 
malformations in traditional Cx43 knockout mouse models, 
Gutstein et al used cardiac restricted inactivation of Cx43 in a 
conditional knockout mouse model to study conduction velocity 
and propensity to arrhythmia. Cardiac restricted inactivation of 
Cx43 was performed using the Cre/loxP system. 
Immunofluorescence revealed almost complete abolishment of 
Cx43 from ventricular myocytes in conditional knockout mice at 4 
weeks of age. Immunoblots revealed up to 95% reduction in Cx43 
expression with no change in Cx40 levels in the ventricles of 
conditional knockout mice compared to littermate controls. 
Histological examination revealed no microscopic differences 
between groups and echocardiography did not reveal any 
structural or functional differences. Knockout mice possessed high 
death rates within the first 2 months of life, and telemetry revealed 
terminal spontaneous ventricular arrhythmias. Langendorff 
preparations and optical mapping was performed in a manner 
similar to Tamaddon et al to assess ventricular conduction.50 
Knockout hearts displayed a 55% and 42% reduction in 
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conduction velocities in the transverse and longitudinal directions 
respectively during ventricular epicardial pacing. They were also 
highly susceptible to spontaneous ventricular arrhythmia 
compared to controls which had none.53 
Leaf et al studied the pattern of atrial Cx40 expression in wild-type 
and knockout mice using a combination of epicardial optical 
mapping during pacing, RNA expression, and protein expression. 
When conduction velocities were assessed in wild-type mice, left 
atrial appendage velocities were higher than right. This difference 
was abolished in both heterozygous and homozygous knockout 
mice. When genotypes were compared, there was only a mild 
reduction in conduction velocities of the left atrial appendage 
between wild-type and heterozygous knockout mice. Cx40 mRNA 
expression was highest in the left atrial appendage compared to 
the right in wild-type mice. This difference was again abolished in 
heterozygous knockout mice. There was no change in Cx43 
mRNA expression between right or left atrial appendages of all 
three genotypes. Subjective assessment of immunofluorescence 
and band densitometry of Western blots revealed no significant 
differences in Cx40 expression between the left and right atria 
however. When wild-type and heterozygous mice were compared, 
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there was a significant reduction in Cx40 mRNA and protein 
levels. Wild-type and knockout embryonic mice atrial appendages 
were also studied with optical mapping at 13.5 days post coitum 
and 15.5 days post coitum. At 15.5 days post coitum, results 
revealed similar atrial conduction velocity trends to that of adult 
mice except that conduction velocity was faster within the right 
atria compared to left of wild-type embryos. This heterogeneity 
was not evident at 13.5 days post coitum. Furthermore, at day 
13.5 post coitum, spontaneous atrial rhythm originated from the 
sinus node in all embryos. By day 15.5 post coitum, spontaneous 
atrial rhythm originated from multiple ectopic sites in knockout 
mice compared to wild-type mice which remained in sinus 
rhythm.54 
Beauchamp and co-workers studies the effects of connexin 40 
and 43 knockout on conduction velocities in an in vitro model of 
neonatal mouse atrial myocytes. High resolution optical mapping 
was used to assess conduction velocities in atrial cultures. 
Homozygous knockout of Cx43 resulted in conduction slowing. 
Although there was also a reduction in junctional Cx40 with 
immunofluorescence, it was inferred that the proportional increase 
in Cx40 to Cx43 was responsible for conduction slowing. 
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Homozygous knockout of Cx40 resulted in an increase in 
conduction velocity. Although there was an increase in junctional 
Cx43 with immunofluorescence, it was inferred that the 
proportional decrease in Cx40 to Cx43 was responsible for 
increased conduction velocities. The increase in junctional Cx43 
with Cx40 knockout was not observed in adult rat hearts however. 
Although the results were consistent with the findings in human 
atria by Kanagaratnam et al, they must be interpreted with 
caution. Firstly, results were confounded by differing quantities of 
the remaining connexin isotype between knockout and wild-type 
atria. Secondly, differences in associated binding affinities and 
relative fluorescence’s of the antibodies used, meant that results 
could not be directly compared to the conductance findings of 
previous patch clamping studies.55 
1.2.2.2 Non-Genetically Engineered Animal Models 
Observational Studies 
As part of a study into radiofrequency ablation of pacing induced 
AF in dogs, Elvan et al used 3 dogs to study the effects of chronic 
pacing alone on Cx43 expression. Dogs underwent endocardial 
high frequency burst pacing of the right atrium for up to 
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approximately 15 weeks to induce AF. When the right atria of 
dogs in AF were compared to sinus rhythm controls, 
immunofluorescence revealed an increase in the level of 
membranous Cx43, while immunoblotting revealed an increase in 
total cellular Cx43.56 
Van Der Velden et al studied the distribution of connexin40 and 43 
in atrial appendages of goats before and 2 months after induction 
of sustained AF via epicardial pacing. Epicardial mapping using a 
244 lead electrode array with an inter-electrode distance of 
2.25mm was also performed with atrial pacing to assess 
conduction velocities before and after AF induction. Just prior to 
the second mapping session, hearts were defibrillated to sinus 
rhythm. Electrode mapping revealed similar epicardial conduction 
velocities before and after induction of AF. PCR and Western 
blotting revealed no difference in cellular Cx40 and Cx43 mRNA 
or protein levels before and after induction of AF. 
Immunofluorescence however revealed patches of cells varying in 
diameter from 150μm to 600 μm that were almost devoid of Cx40 
interspersed between areas of cells with normal Cx40 levels 2 
months after induction of AF. There was no difference in the 
pattern of Cx43 distribution before and after AF induction. The 
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results suggested that heterogonous Cx40 distribution may 
reduce the safety factor for conduction without altering the overall 
conduction velocities and that the resolution of mapping was not 
high enough to pick up altered conduction velocities within areas 
of reduced Cx40 expression.57 
Van Der Velden et al subsequently used a similar model to assess 
the time course for connexin changes in the left and right atria of 
goats subject to atrial pacing. Goats however this time received 
endocardial burst pacing. Paced goats were assessed either at 1, 
2, 4, 8, or 16 weeks from commencement of pacing and 
compared to non-paced goats that remained in sinus rhythm. Prior 
to sacrifice, goats were considered to be in stable AF if 
spontaneous termination did not occur within the preceding 3 
hours with the pacemaker switched off. There was an increased 
incidence of stable AF as pacing time increased, with all goats at 
16 weeks possessing stable AF.  Immunofluorescence of atria 
from each time point revealed increasingly heterogeneous Cx40 
distribution on myocytes and increasingly greater areas of 
myocytes almost devoid of this protein. Increasing levels of 
myolysis paralleled the decrease in Cx40 expression. The pattern 
of Cx43 expression however remained unchanged. 
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Immunoblotting revealed a reduction in cellular Cx40. While there 
was no difference in cellular Cx43, there was a shift towards 
greater phosphorylated Cx43 over time. There was no change in 
mRNA levels for connexins 40 and 43 however. Changes in Cx40 
expression also varied between left and right atria. The results 
suggested that longer atrial burst pacing resulted in greater 
changes in Cx40 heterogeneity which in turn resulted in an 
increasing propensity for AF.58 
Pharmacotherapy Studies  
Further evidence that connexins played a role in conduction and 
arrhythmia came from the study of compounds that modulate gap 
junction function. The effect of Rotigaptide on atrial conduction 
and the propensity for AF in dogs was studied by Guerra et al. 
Three groups of dogs were used. The first consisted of control 
animals that had no surgical intervention. The second consisted of 
dogs with mitral regurgitation secondary to valve avulsion. The 
last consisted of dogs with ventricular pacing induced heart 
failure. Baseline epicardial electrode array mapping and AF 
induction was performed on all animals, specifically at 6 weeks 
after valve avulsion, and at 4 weeks after onset of ventricular 
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pacing. Studies were repeated on all animals during the same 
sitting, before and 20 minutes after commencement of infusions of 
Rotigaptide designed to achieve serum concentrations of 10, 50, 
and 200nmol/L. At baseline, epicardial conduction velocities 
tended to be slower in the valve avulsion and pacing groups and 
were associated with increased vulnerability for burst pacing 
induced AF when compared to control animals. Following 
administration of Rotigaptide, there was an increase in left and 
right atrial conduction velocities of the control and valve avulsion 
groups. In the pacing group however, there was no change in 
conduction velocity in the left atrium and a mild increase in the 
right atrium. AF vulnerability within the valve avulsion group was 
normalised following administration of Rotigaptide to serum 
concentrations of 10 and 50nmol/L. This reduction however 
dropped off with Rotigaptide serum concentrations of 200nmol/L. 
Rotigaptide did not alter AF vulnerabilities within the pacing group. 
Although spatial distributions of Cx40 and Cx43 were similar 
between all three groups with immunofluorescence, there was an 
approximately 3 fold increase in the percentage of fibrosis in atrial 
sections from the pacing group when compared to the other two 
groups. This may have accounted for the lack of response to 
Rotigaptide within the pacing group.59 
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Shiroshita-Takeshita et al also studied the effects of Rotigaptide 
on conduction and propensity to arrhythmia but in 3 different 
canine models of AF. The first model consisted of atrial pacing 
with assessment at 3 weeks and 6 weeks. The second consisted 
of the ventricular pacing heart failure model with assessment at 2 
weeks. The third consisted of acute atrial ischemia. EPS and 
mapping via epicardial electrode arrays were performed prior to 
and after administration of Rotigaptide and compared to 
respective instrumented but not paced sham controls. Rotigaptide 
had no effects on effective refractory periods and conduction 
velocities in all sham controls. At 3 and 6 weeks, atrial pacing 
resulted in longer effective refractory periods. Rotigaptide had no 
effect on effective refractory periods, but slightly increased 
conduction velocities in this group. Ventricular pacing did not alter 
effective refractory periods. Like the atrial pacing group however, 
Rotigaptide had no effect on effective refractory periods, and 
mildly increased conduction velocities. Atrial ischemia did not 
change effective refractory periods as well. There was however 
significant conduction slowing within ischemic areas. While 
Rotigaptide again had no effect on effective refractory periods, 
there was a significant attenuation of conduction slowing within 
ischemic areas at 3 and 5 hours. Conduction heterogeneity 
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indexes of localised conduction slowing were significantly 
increased in the ischemia and ventricular pacing models 
compared to sham controls. Rotigaptide significantly attenuated 
conduction heterogeneity index changes in the setting of 
ischemia, but not ventricular pacing induced heart failure. AF 
durations were prolonged in all groups compared to controls, and 
Rotigaptide significantly attenuated these durations. This 
reduction was small within the atrial pacing group. However within 
the ischemic group, AF duration was reduced to sham control 
levels.60 
A more recent study of the gap junction modifier GAP-134 was 
performed by Rossman et al. Initially, the effect of the gap junction 
modifier GAP-134 on atrial conduction velocity and propensity for 
AF in the setting of stress was studied. Two models were 
assessed. In the first, strips of left atrial tissue were perfused with 
regular Tyrodes buffer. Stress was induced by altering perfusate 
to non-oxygenated, glucose free Tyrodes buffer. Stress was 
assessed in the presence and absence of GAP-134.  Conduction 
velocities, measured by two electrodes oriented parallel to the 
long axis of the strips, rapidly dropped off with stress in the 
absence of GAP-134, while they were maintained at baseline 
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levels in the presence of GAP-134. Further study was performed 
using a canine model of sterile pericarditis. Conduction velocity 
was significantly increased in the presence of GAP-134. 
Furthermore, there was a reduction in duration and vulnerability of 
pacing induced AF after the administration of GAP-134. This 
effect was not observed in animals that did not receive GAP-134. 
Immunoblotting for Cx43 in the left atrium of both groups did not 
demonstrate any effect of GAP-134 on cellular expression 
levels.61  
Gene Therapy Studies 
Bikou et al was the first to utilise acute somatic gene transfer 
techniques to study the role Cx43 played in a porcine, pacing 
induced model of AF. Animals were assigned to receive an 
adenovirus encoding either GFP or Cx43 followed by 14 days of 
burst pacing to induce AF. Viral vector was applied by multiple 
direct injections into the left and right atria followed by 
electroporation at the atrial surface.  A third group of pigs received 
no vector or pacing and acted as a sinus rhythm control. At day 
14, all animals that underwent GFP transduction were in 
persistent AF as defined by greater than 48 hours of continuous 
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AF. Conversely, all animals that underwent Cx43 transduction 
were predominantly in sinus rhythm. Paroxysmal AF was 
observed in 3 animals within the Cx43 group. Animals with 
persistent AF had a 62% reduction in cellular Cx43 compared to 
sinus rhythm controls as determined by Western blotting. A 
significant decrease was not observed in the Cx43 gene transfer 
group. Immunohistochemistry revealed a 2.0 fold increase in 
membranous Cx43 levels, primarily at the intercalated discs, in 
animals from the Cx43 group compared to the GFP group. Cx43 
therapy did not alter the levels of Cx40. Atrial surface conduction 
velocities, assessed in vivo by an epicardial electrode array, were 
62% greater in the Cx43 group compared to the GFP group. Left 
ventricular ejection fractions, assessed by echocardiography 
mirrored the conduction velocity findings. The study did not 
assess other factors such as inflammation or fibrosis. 
Furthermore, no sinus rhythm controls with GFP therapy and no 
pacing controls without GFP therapy were used to assess for the 
possible effects of GFP therapy itself on Cx43 expression and 
epicardial conduction velocities. This study however was the first 
to suggest the possibility of reducing AF vulnerability with Cx43 up 
regulation.62 
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Also using acute somatic gene transfer techniques, Igarashi et al 
assessed the effects of Cx40 and Cx43 overexpression in a 
pacing induced porcine model of AF. Thirty swine were divided 
into 2 groups, namely, a sinus rhythm group, and a burst pacing 
induced AF group. Each group was further divided into 3 
subgroups, namely, a sham operated control subgroup, or one of 
two gene therapy subgroups receiving either Cx40 or Cx43 via an 
adenoviral vector. Baseline EPS’s were performed followed by the 
atrial application of a viral vector to the appropriate subgroups. A 
camel hair brush was used to apply a gel mix containing vector, 
poloxamer, and trypsin, to the epicardial surface. Pacemakers 
were inserted into the groups targeted for burst pacing induction 
of AF. Swine were observed daily and a final EPS was performed 
on day 7 followed by cardiac extraction for optical mapping, 
histology, Western blotting, and immunohistochemistry. As 
expected, all control animals within the burst pacing group were in 
continuous AF by day 7, while no animal within the sinus rhythm 
group developed AF. Animals within the burst pacing group that 
received gene transfer had a lower percentage of time in AF at 
day 7 compared to sham operated controls. Compared to sinus 
rhythm sham controls, AF sham controls possessed a significant 
reduction in total and phosphorylated Cx43 levels and unchanged 
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Cx40 levels by Western blotting, an almost 50% reduction in the 
percentage of membranous Cx43 located at the intercalated disc 
on immunofluorescence, and longer P wave durations, inter-atrial 
conduction times, and surface conduction velocities with 
electrophysiological assessment. Cx43 gene transfer to animals 
within the burst pacing group virtually normalised these 
parameters. Interestingly Cx40 gene transfer did not alter Cx40 or 
Cx43 intercalated disc levels within the burst pacing group. 
Cellular levels of Cx40 were however increased by Cx40 gene 
transfer. Importantly, no vector control group was used within this 
study to confirm that adenovirus itself was not responsible for the 
results observed, particularly within the Cx40 group. Nevertheless, 
the Cx43 findings were similar to that of Bikou et al.62, 63 
1.2.2.3 Human Studies 
Kanagaratnam and co-workers attempted to identify a correlation 
between the relative expression of connexins 40 and 43 and atrial 
conduction velocity in humans. During coronary artery bypass 
surgery, electrophysiology studies were performed via a grid of 
epicardial electrodes (16 X 7 array, 3.5mm inter-electrode 
spacing) attached to the right atrium. Biopsies were taken to 
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quantitate connexin isotype expression levels with 
immunofluorescence. During sinus rhythm, an increase in Cx40 
levels and the ratio of Cx40 to summed Cx40 and Cx43 levels 
was associated with conduction slowing. Furthermore, during 
sinus rhythm, while an increase in Cx43 levels was not associated 
with alterations in conduction velocity, an increase in the ratio of 
Cx43 to summed Cx40 and Cx43 was associated with an increase 
in conduction velocity. These correlations were abolished 
however, with a reduction in the coupling interval by atrial pacing 
from the area of the sinus node. Interestingly, relative Cx40 
expression correlated with rate related changes in conduction 
velocity, suggesting a role in rate adaptation. Interpretation of 
results within this study were however limited. Firstly, the mapped 
area was large with low spatial resolution and likely subject to 3D-
wave propagation error. This may have also accounted for the 
alteration in conduction velocities observed between pacing and 
sinus rhythm. Secondly, differences in associated binding affinities 
and relative fluorescence’s of the antibodies used, meant that 
results could not be directly compared to the conductance findings 
of previous patch clamping studies.64 
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Dupont et al studied right atrial appendage expression of Cx40 
and Cx43 in humans with and without sustained acute AF 
following coronary artery bypass grafting. All patients had no prior 
history of AF. Analysis of a limited set of possible confounding 
factors such as atrial size and left ventricular ejection fraction 
revealed no significant difference between groups. Analysis 
however did not include underlying medical history or medication 
use. Compared to patients without AF, mRNA and total cellular 
protein levels for Cx40 were elevated in patients with AF. There 
however was no difference in Cx43 mRNA and protein levels 
between both groups. Although the results suggested that 
increased total cellular Cx40 expression increased the risk of 
developing AF, no assessment was made to see if this increase 
translated into an increase in Cx40 at the intercalated discs where 
intercellular conduction is facilitated. Interestingly, 
immunofluorescence revealed heterogeneous expression of Cx40 
within the atria of both groups. Cx43 expression was homogenous 
in both groups. No histological assessments were performed 
however for ischemia, inflammation or fibrosis. This is particularly 
important given the background of an ischaemic disorder in all 
patients, and the rapid occurrence of sterile pericarditis on 
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pericardial instrumentation, both of which have the ability to alter 
connexin distribution.65-67  
Polontchouk et al subsequently compared the expression of 
connexins 40 and 43 in the right atrial appendages of patients with 
and without chronic AF at the time of open heart surgery. The 
reasons for surgery were coronary artery bypass grafting and/or 
correction of a valvular defect. The proportion of patients 
undergoing each type of surgery appeared similar between both 
groups. Immunoblotting revealed an increase in cellular Cx40 
levels and no change in cellular Cx43 levels in patients with AF. 
Analysis of the membranous distribution of connexins with 
immunofluorescence revealed no difference in connexin 40 and 
43 levels at the outer end quarters of myocytes between patients 
with and without AF. However there was an increase in connexin 
40 and 43 levels in the mid half of myocytes indicating 
lateralisation in patients with AF. The implications of the observed 
changes in connexin expression were then assessed using a 
model of pacing induced acute AF in rats. Acute AF was 
generated by atrial pacing explanted Langendorff perfused right 
atria for 24 hours. Two control groups were used. The first 
consisted of right atria not subjected to Langendorff perfusion, and 
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the second consisted of right atria subjected to Langendorff 
perfusion for 24 hours without pacing. Following 24 hours of 
pacing, AF was present in all atria for up to 5 minutes at most. 
Non-paced Langendorff perfused hearts remained in sinus 
rhythm. Surface conduction velocities were assessed with atrial 
pacing at the edge of a linear array of 4 electrodes (3mm inter-
electrode spacing) placed transversely and subsequently 
longitudinally to surface fibre orientation. There was a non-
significant (p=0.1) increase in transverse fibre conduction velocity 
from 5cm/s to 8cm/s in the pacing group. There were no 
differences in longitudinal conduction velocities between groups. 
Immunoblotting and immunofluorescence revealed differences in 
connexin expression between sinus rhythm and AF that were 
similar to the human studies. The findings suggested that 
connexin lateralisation improved transverse conduction, reduced 
conduction anisotropy, and hence increased the propensity for 
AF. The results must be interpreted however in the setting of the 
method used to assess conduction velocity, which was likely 
subject to angulation error and limited in its ability to detect 2 and 
3 dimensional conduction.68 
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The pattern of Cx40 and Cx43 expression between different 
regions of the right atrium of humans with and without chronic AF 
was assessed by Kostin et al. All patients with AF underwent a 
mini-Maze procedure. Although patients with sinus rhythm were 
matched to patients with AF by right and left atrial sizes, the 
reasons for their surgery was not specified. Patients with AF 
tended to have more valvular heart disease. Biopsies of the atrial 
appendage and free wall of the right atrium were assessed with 
immunofluorescence. Consistent with earlier studies, results 
revealed a marked lateralisation of connexins 40 and 43 in both 
atrial areas of patients with AF compared to sinus rhythm. In 
addition, patients from both groups possessed heterogonous 
expression of Cx40 with areas of lower levels of expression to 
adjacent regions of normal Cx40 levels. However the total area of 
heterogeneity was lower in patients with sinus rhythm. Cx43 
expression was homogenous in both groups. The total level of 
membranous Cx43 expression was reduced by approximately 
57% in both biopsy areas of patients in AF compared to sinus 
rhythm. Total membranous Cx40 expression was reduced by 54% 
in atrial appendages, but trended towards a 16% increase in the 
free walls of patients with AF when compared to controls. 
Increased fibrosis was also noted in patients with AF.69 
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Nao et al studied patterns of connexin 40 and 43 expression in 
humans with chronic AF in the setting of mitral valve disease. 
Right atrial appendage tissue was collected from patients at the 
time of open heart surgery. Two control groups were used, the 
first being patients in sinus rhythm with mitral valve disease, and 
the second being patients in sinus rhythm without mitral valve 
disease and undergoing coronary artery bypass grafting. Results 
revealed a reduction in Cx40 protein by immunoblotting and 
mRNA levels by PCR in the setting of chronic AF. There was 
however an increase in serine phosphorylation of Cx40 within the 
AF group compared to both controls. No significant difference 
between groups was found in Cx43 mRNA, protein or 
phosphorylation levels. Immunofluorescence revealed a pattern of 
heterogonous Cx40 expression in patients with valvular heart 
disease, being worse in patients with AF. Furthermore, total 
membranous signal was lower in patients with mitral valvular 
disease. Due to ethical reasons, epicardial conduction velocity 
assessment was not performed.70 
Kanagaratnum et al subsequently studied the relationship 
between right atrial connexin 40 and 43 expression and epicardial 
surface activation in the setting of acute and chronic AF. Acute AF 
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(lasting longer than 30 seconds) was studied in patients in sinus 
rhythm, without a history of AF, and undergoing coronary artery 
bypass surgery. Acute AF was generated at the time of surgery 
through burst pacing of the right atrium. Chronic AF was studied 
predominately in patients undergoing valvular replacement, with 
only 1 patient undergoing coronary artery bypass grafting, and 
another undergoing an atrial septal defect repair. The pattern of 
epicardial activation was assessed using a rectangular array of 
112 electrodes (with 3.75mm spacing) or 225 electrodes (2.25mm 
spacing). Complexity of activation was assessed based on the 
number simultaneous wavefronts seen to pass over the area of 
the array in consecutive windows of a 2 second time period. 
Mapping revealed no difference in the complexity of epicardial 
activation between patients with acute or chronic AF. 
Immunofluorescence revealed heterogonous Cx40 expression in 
all chronic AF patients and only 60% of patients in the acute AF 
group. The degree of Cx40 heterogeneity was the same between 
patients with heterogeneity in both groups. There was no 
difference in Cx43 signal between both groups and homogenous 
expression was always observed. In patients with chronic AF, 
complexity of activation was inversely associated with Cx40 signal 
and the ratio of Cx40 to summed Cx40 and Cx43 signals. This 
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relationship however, was not observed in acute AF patients and 
Cx43 levels did not correlate with complexity in either group. The 
results suggested that changes in other factors associated with 
the underlying disease process may also be required before 
alterations in Cx40 and Cx43 ratios produced meaningful 
correlations with AF.71 
The pattern of ion channel expression in addition to connexins 40 
and 43 in patients with and without AF was studied by Gaborit et 
al. Three groups of patients were used. The first consisted of 
patients in sinus rhythm in the setting of coronary artery disease. 
The second consisted of patients in sinus rhythm with valvular 
heart disease. The last consisted of patients in AF with valvular 
heart disease. Gene microarray analysis revealed a significant up 
regulation of Cx43 and down regulation of Cx40 in patients with 
valvular heart disease compared to patients with coronary artery 
disease. Two way hierarchical analyses however revealed no 
differences of both connexins between patients with AF and sinus 
rhythm in the setting of valvular heart disease. Real time PCR for 
Cx40 and Cx43 mRNA was consistent with the gene array results. 
Protein levels assessed with Western blotting mirrored the gene 
expression results. Importantly there were significant differences 
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in other ion channels including that of potassium and calcium at 
the gene, protein, and patch clamping levels between patients 
with and without AF in the setting of valvular heart disease. The 
findings confirmed that factors such as ion channel expression 
were also altered in AF, supporting the idea that a threshold of 
conduction heterogeneity was required for the genesis of AF. The 
results also highlighted the importance of appropriate controls 
when assessing differences to ensure an accurate understanding 
of the significance of results.72 
Wetzel et al also studied the pattern of Cx40 and Cx43 expression 
in the atria of patients with and without AF. Study groups 
consisted of patients in sinus rhythm in the setting of either 
valvular or coronary heart disease, patients with lone AF 
undergoing intra-operative radiofrequency ablation, or patients 
with AF in the setting of mitral valve disease. Patients with lone 
AF were significantly younger while patients with AF and valvular 
disease had significantly larger left atria. Tissue samples were 
obtained from the left atrium. The only exception were patients 
with sinus rhythm undergoing coronary artery bypass grafting 
where right atrial appendage tissue was used. Quantitative 
densitometry of Western blots revealed a small but significant 
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increase in Cx40 levels and a large increase in Cx43 levels in 
patients with AF when compared to sinus rhythm controls. Further 
analysis revealed that the increase in Cx40 was due to patients 
with lone AF, while the increase in Cx43 was due to patients with 
AF in the setting of valvular disease. When the results of patients 
with the lone AF and valvular AF groups were further divided into 
paroxysmal or chronic AF, there was no difference in the levels of 
Cx40 and Cx43 when compared to patients in sinus rhythm. In 
addition, there was no difference in connexin levels between 
patients with and without valvular heart disease. Based on the 
findings of Kostin et al and Leaf et al where connexin expression 
varied between different sections of atrial, the results were difficult 
to interpret given that origin of tissue samples in 60% of sinus 
rhythm controls were different to patients with AF.54, 69, 73 
Rucker-Martin et al studied the pattern of expression of Cx40 and 
Cx43 in the right atrial appendages from patients undergoing open 
heart surgery. Study groups consisted of patients in sinus rhythm 
with normal sized atria and underlying coronary artery disease, 
patients with chronic AF and atrial dilation in the setting of valvular 
heart disease, and patients in sinus rhythm with dilated atria in the 
setting of predominately valvular heart disease. Compared to the 
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non-dilated atrial control group, atrial tissue from patients with 
dilated atria demonstrated lateralisation of Cx40 and Cx43 on 
immunofluorescence. In addition, there was a decrease in the 
cellular ratio of phosphorylated to non-phosphorylated Cx43, and 
a decrease in Cx40 expression on Western blotting. Importantly 
however, no loading controls for western blot analysis were used 
making the significance of the Cx40 results difficult to interpret.74 
The results of the preceding human studies suggest that a 
variable and complex inter-related threshold of tissue 
heterogeneity comprised not only of alterations in Cx40 and Cx43 
ratios, but also other factors such as connexin phosphorylation 
and lateralisation, ion channel expression, and fibrosis must be 
reached to create a substrate suitable for supporting AF. It is also 
likely that the differing patterns of connexin alterations observed 
within each of these studies are affected by the underlying 
disease processes of the recruited patients. While valvular heart 
disease is likely to result in heart failure secondary to volume 
overload, ischaemic heart disease can alter atrial connexin 
expression directly through lack of tissue oxygenation and 
indirectly through ventricular failure74, 75.  
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1.2.3 Summary 
In summary, based on the preceding literature review, it is clear 
that connexins have the ability to modulate tissue conduction 
velocity and anisotropy, and through aberrant expression also 
have the ability to lower tissue vulnerability thresholds for the 
development of arrhythmia. 
Connexin expression is clearly dynamic and subject to many 
intracellular and extracellular factors. Macroscopic junctional 
conductance is affected by cell type and has a non-linear 
relationship to connexon isotype composition. Other influential 
factors of conductance include the degree of connexin 
phosphorylation, connexin location, and total junctional connexin 
content. These factors vary from location to location within the 
same cardiac chamber, and are subject to further influences 
including blood supply, chamber pressures, and beat frequency. 
An added layer of complexity occurs when changes such as 
genetic engineering, somatic gene transfer, or arrhythmia 
induction are applied.  
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One of the biggest problems with human and animal studies has 
been the use of controls from different disease states. Clearly 
patients with sinus rhythm and ischemia are not adequate controls 
for patients with AF and valvular heart failure. Appropriate vector 
controls need to be used with somatic gene transfer techniques so 
as to fully understand the outcomes. Genetically engineered 
models need to be adequately assessed to explain discrepancies 
such as the presence of AV synchrony despite the apparent 
knockout of all connexins within the His bundle. Clearly such an 
animal must either still be a chimera with an incomplete level of 
connexin knockout in the His bundle, or have a congenital 
accessory AV pathway. Lastly, when assessing outcomes such as 
conduction velocities and foreknowing the scale of heterogeneity, 
mapping systems with high enough resolution should be utilised. 
A striking feature upon reviewing this literature is the considerable 
variation and often opposing patterns of connexin expression 
between similar study models. This highlights the difficulty, but 
also necessary importance of choosing the right model and 
considering all factors that may influence conduction, when 
designing a study into connexins.  
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Based on the above-mentioned considerations, the technique of 
somatic gene transfer presents itself as the best way to assess 
the true functional significance of relative connexin isotype 
expression levels, and of connexin mutations.  With appropriate 
controls including a vector control, and a wild-type connexin 
control, the confounding factors and problems identified within this 
literature review can be avoided. 
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CHAPTER 2 
Materials and General Methods 
This chapter describes the general methods employed within this 
research project. Specialised methods or variations of these 
general methods are described in their respective results 
chapters. 
2.1 Molecular Biology 
2.1.1 Chemicals, reagents, and plastic/glassware 
Only analytical grade chemicals and reagents were used and the 
suppliers of these are indicated throughout the text. In addition, 
only reagent grade water (MQH20) was used when solution 
production required water. All plastic and glassware were washed, 
rinsed with MQH20, and autoclave sterilised prior to use. 
2.1.2 Bacterial strains and plasmids 
Only the Escherichia coli bacterial strain JM109 (genotype: 
endA1, recA1, gyrA96, thi, hsdR17 (rk-,mk+), relA1, supE44, Δ(lac-
proAB), [F’, traD36, proAB, laqIqZΔM15]; source: Promega) was 
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used to propagate plasmid DNA. The plasmids used within this 
research are described in Tables 2.1 and 2.2. Each plasmid 
possessed an ampicillin resistance gene. 
2.1.3 Bacterial growth media 
Escherichia coli was grown in Luria-Bertani (LB) broth or on solid 
LB-agar. Fresh broth was prepared when required using 0.5% 
(w/v) yeast extract (Sigma-Aldrich), 1% (w/v) tryptone (Sigma-
Aldrich), and 1% (w/v) sodium chloride (Sigma-Aldrich) dissolved 
in MQH20.  Bacteriological agar 1.5% (w/v) was added to fresh 
broth when LB-agar was required. All media was autoclave 
sterilised at 121°C for 20 minutes. To facilitate selective growth of 
successfully transformed JM109 cells during propagation, 
ampicillin (100μg/mL) was added to media once cooled. In the 
case of LB-agar, this was at approximately 55°C, prior to pouring 
into 10cm petri dishes. 
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2.1.4 Propagation of plasmids 
2.1.4.1 Preparation of electro-competent cells 
From a glycerol stock, non-transformed Escherichia coli (JM109) 
was streaked onto a fresh LB-agar plate and incubated at 37°C. 
The following afternoon, a single bacterial colony was used to 
inoculate 5mls of LB-broth. This was incubated overnight at 37°C 
on an orbital shaker set to 220rpm. The resulting bacterial 
suspension was added to 500mL of LB broth and incubated at 
37°C on an orbital shaker until the cultures reached a mid-log 
phase of growth as determined by spectrophotometry, 
(absorbance of 0.4 at 600nm). This was approximately 3 hours. 
The bacterial suspension was transferred to 2 polypropylene 
centrifuge bottles and centrifuged at 3000 x g at 4°C for 2 
minutes. The supernatant was discarded and the cells gently 
resuspended in 250mls of ice cold Transformation Buffer (TB) 
buffer. The cells suspension was incubated on ice for 30 minutes 
before centrifuging again at 3000 x g at 4°C for 2 minutes. The 
supernatant was discarded and the cells were resuspended in 1ml 
of 10% w/v glycerol (Sigma-Aldrich). Cell suspension aliquots of 
40μL were put into microcentrifuge tubes, snap frozen in liquid 
nitrogen, and stored in a -80°C freezer. The transformation 
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efficiency was assessed by transforming a known quantity of 
plasmid DNA into an aliquot of cells and counting the colonies 
grown on selective LB-agar plates. The efficiency of these cells 
was >2.0 x 107 transformants per μg of DNA. 
2.1.4.2 Bacterial transformation with plasmid DNA 
A 40μL aliquot of JM109 electro-competent cells and plasmid 
stock were thawed on ice. One microliter of plasmid stock, 
containing between 50 to 500ng of DNA, was added to the 
bacterial cells. The mixture was transferred to a pre-chilled 
electroporation cuvette. The cells were pulsed once with 200Ω 
resistance and capacitance of 960μF at 1.7kV using a Bio-Rad 
Gene Pulser II electroporator. This produced a time constant of 
approximately 4.5ms. Immediately following electroporation, 
200μL of SOC medium was added to the cuvette. The cell 
suspension was transferred to a microcentrifuge tube and 
incubated at 37°C for 1 hour. A 10 fold dilution with SOC medium 
was performed and a 100μL aliquot was plated onto LB agar for 
incubation overnight at 37°C. 
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2.1.4.3 Large scale preparation of plasmid DNA 
A starter culture was produced by inoculating 5mL of LB broth 
with a single colony of transformed cells in a 14mL polypropylene 
tube and incubating the resulting suspension on an orbital shaker 
for 8 hours at 37°C.  The starter culture was added to 150mL of 
LB broth in a 1L conical flask and incubated on an orbital shaker 
at 220rpm at 37°C overnight. The following morning, a glycerol 
stock was made by gently mixing 850μL of the resulting bacterial 
suspension with 150μL of glycerol (Sigma-Aldrich) and 
subsequently stored in a -80°C freezer. The rest of the 
suspension was pelleted at 6000 x g for 15 minutes at 4°C. The 
supernatant was discarded and the bacterial pellet processed with 
the alkaline lysis method, using a commercially available Qiagen 
HiSpeed Plasmid Maxi Kit according to the manufacturer’s 
protocol. The cell pellet was resuspended in 10mL of buffer P1 
containing RNase A. Lysis was enacted with the addition of 10mL 
of buffer P2 and subsequent incubation for 5 minutes at room 
temperature. Genomic DNA, protein, and cell debris were 
precipitated with the addition of 10mL of chilled buffer P3 and 
subsequent incubation for 10 minutes at room temperature. 
During the incubation period, a HiSpeed Maxi Tip was equilibrated 
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with 10mL buffer QBT. The lysate was filtered with a QIAfilter 
cartridge onto the HiSpeed Maxi Tip and allowed to pass through 
the resin by gravity flow. The HiSpeed Maxi Tip was washed with 
60mL of buffer QC and the DNA eluted using 15mL of buffer QF 
into a 50ml polypropylene tube. DNA was precipitated by 
incubation with 10.5mL of 100% (v/v) isopropanol (Sigma-Aldrich) 
for 5 minutes. The eluate/isopropanol mixture was filtered through 
a QIAprecipitator. The QIAprecipitator was washed with 2mL of 
70% (v/v) ethanol (Fronine) and air dried. DNA was subsequently 
eluted with 1mL of TE buffer. DNA concentration and purity of the 
new plasmid stock was assessed with spectrophotometry prior to 
storage in a -80°C freezer. The yield of plasmid DNA varied 
between 0.5mg to 1.5mg. 
2.1.5 Estimation of plasmid DNA concentration and 
purity 
Spectrophotometry was routinely used to assess plasmid DNA 
samples. Absorbances at wavelengths of 260nm and 280nm were 
used to determine plasmid DNA concentration and purity. This 
method assumed that 50μg of dsDNA has an absorbance of 1.0 
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at 260nm while pure dsDNA has a 260/280 absorbance ratio of 
1.8. 
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2.2 Cell Culture 
2.2.1 Cell lines, reagents, and plastic/glassware 
The cell lines used during this project are listed in table 2.2.  
Cell culture media was freshly supplemented with the cell culture 
grade reagents specified in Table 2.2 prior to the commencement 
of individual experimental protocols.  
For subculture and other manipulations, HEK293T cells were 
washed with Dulbecco’s Phosphate Buffered Saline (DPBS) 
lacking calcium and magnesium (Lonza) and detached and 
disaggregated using 0.05% Trypsin/0.5mM EDTA solution 
(Sigma-Aldrich). 
Sterile filtered fetal bovine serum (FBS; SAFC Biosciences), was 
stored at -20 ºC and heat inactivated prior to use by warming to 
37ºC for 30 minutes.  
Cell culture plastic ware including culture flasks and serological 
pipettes were obtained from Falcon and Corning and used only 
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once. Glassware was washed, rinsed with MQH20 and autoclave 
sterilized prior to each use. 
2.2.2 General cell culture methods 
Published cell culture methods were employed in this research 
project.76 Cells were grown in disposable polystyrene 
flasks/dishes (Falcon or Corning) or sterile glassware containing 
their respective media as detailed in Section 2.2.1. All cultures 
were grown in a 5% CO2 environment at 37ºC. 
2.2.2.1 Cell counting using a haemocytometer 
Cell suspensions were counted at a concentration of 105 to 106 
cells per millilitre. A 100uL aliquot of cells was mixed with an 
equal volume of 0.5% trypan blue (Sigma-Aldrich). A 15uL aliquot 
was applied beneath each side of a cover slipped 
haemocytometer (Brand). Live cells were counted using a 10X 
objective of an inverted microscope (Olympus CK2). The number 
of cells in the 4 major outer corners of each of the 2 chambers (8 
squares in total) was averaged, corrected for dilution, and 
multiplied by 104 to give the number of cells per mL.  
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Table 2.2: Cell types used in cell culture experiments 
Cell Type Description Source Medium 
HEK293T Transformed 
human embryonic 
kidney cells 
ATCC number: 
CRL-11268 
1 
NRVM Primary Day 2-3, 
neonatal rat 
ventricular 
myocytes 
Adult Sprague 
Dawley rats, 
Animal 
Resources 
Centre, Western 
Australia 
2,3,4,5 
1. Dulbecco’s Modified Eagles Medium (DMEM; Invitrogen) 
supplemented with 10% (v/v) FBS (SAFC Biosciences) and 
2mM glutamine (Invitrogen) 
2. Hank’s Balanced Salt Solution (HBSS; Invitrogen) 
3. HBSS with 1mg/ml Ultrapure Trypsin (Trypsin 4.066 USP 
u/mg, Chymotrypsin 12.13 USP u/mg; USB Corporation) 
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4. HBSS with 1mg/ml Collagenase Type 2 (245u/mg; 
Worthington) 
5. Medium 199 (Invitrogen) supplemented with 1% HEPES 
Buffer Solution (Invitrogen), 1% MEM Non-Essential Amino 
Acids (Invitrogen), 1.75g Glucose (Sigma-Aldrich), 2mM L-
Glutamine (Invitrogen), 1.5μm/L Vitamin B12, 20U/mL 
Penicillin solution (Sigma), and 2% or 10% (v/v) FBS (SAFC 
Biosciences).  
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2.2.2.2 Subculture of adherent HEK293T cells 
When cultures became confluent or were required for 
experimentation, cells were subcultured by enzymatic detachment 
and replating. Culture media was aspirated from the flask and the 
cells were washed once with PBS. A total of 2mL of 0.05% 
Trypsin/EDTA solution was added to the culture and placed at 37 
ºC for 2 minutes to allow cell detachment. Trypsin was 
subsequently inactivated by the addition of culture media. The 
media was pipetted up and down approximately 5 times to further 
dislodge cells and then transferred to a polypropylene tube for 
centrifugation at 1500 revolutions per minute for 5 minutes. Media 
was decanted and the pellet resuspended in fresh culture media. 
An aliquot of the cell suspension was seeded into a new culture 
flask according to the dilution required. Cells were split 2 to 3 
times per week depending on their growth characteristics. 
2.2.2.3 Short and long term storage of HEK293T cells 
Cells to be frozen were detached by trypsinisation during 
exponential growth and pelleted by centrifugation (300 x g, 5 
minutes). Media was aspirated and the cells resuspended at 1-2 X 
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106 per mL in storage media consisting of culture media with 20-
50% FBS and 10% (v/v) DMSO (Sigma-Aldrich). Cell suspension 
aliquots of 1mL were placed in sterile cryovials (Nunc) and stored 
at -80 ºC. Cells for long term storage were moved to liquid 
nitrogen the following day. 
Cells to be recovered from short and long term storage were 
thawed rapidly in a 37ºC water bath. To remove DMSO, the 
contents of a cryo-vial was mixed with 9mls of warmed (37ºC) 
culture media, pelleted at 300 x g for 5 minutes and resuspended 
in fresh culture media following aspiration of the supernatant. 
2.2.3 Neonatal rat ventricular cardiomyocyte cultures 
2.2.3.1 Plating surface preparation 
On the day of ventricular harvesting from rat pups, surfaces 
intended for cardiomyocyte culturing were sterilised with ultraviolet 
light for 1 hour. Following sterilization, surfaces were coated at 
room temperature using a fresh 25mg/ml solution of fibronectin 
powder (BD Biosciences) dissolved in MQH20 that had been 
previously filter sterilised with a 0.45μm PVDF syringe driven filter 
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unit (Millipore). The fibronectin solution was aspirated from culture 
surfaces just prior to the plating of cardiomyocytes. 
2.2.3.2 Isolation of neonatal rat ventricular 
cardiomyocytes 
Ethics approval was received prior to dissection. Two litters of rat 
pups were used for each dissection. Pups were sprayed with 70% 
ethanol, decapitated with a large pair of straight surgical scissors 
(Roboz Surgical Instrument Co), and their chests opened with 
angled delicate scissors (Roboz Surgical Instrument Co). 
Ventricles were excised, placed into ice cold HBSS, and 
quartered. Following 2 rinses with ice cold HBSS, ventricular 
tissue was transferred to a glass jar containing 40mL of 
trypsin/HBSS solution, and agitated on an orbital shaker at 75rpm 
at 4ºC for 16 hours. Following trypsinization, the media was 
aspirated and discarded. Warm 10% serum culture media was 
added and gently agitated in a 37ºC water bath for 4 minutes. The 
media was then aspirated and discarded. Fresh 
collagenase/HBSS (8mL) was added to the tissue and gently 
agitated in a 37ºC water bath for 1 minute. The collagenase/HBSS 
solution was aspirated and discarded. A fresh 8mL of 
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collagenase/HBBS solution was again added to the tissue and 
gently agitated in a 37ºC water bath for 1 minute. The tissue and 
media was pipetted up and down once with a 10mL serological 
pipette to assist with myocyte dissociation. The media was 
aspirated and added to ice cold HBSS and kept on ice. A further 
8mL of collagenase/HBSS was added to the tissue and the 
process repeated 3 times. The 4 aliquots of HBSS solution 
containing dissociated cells were pelleted at 50 x g at 4ºC for 8 
minutes. The supernatant was aspirated and the pellets 
resuspended in 8mL of ice cold HBSS. The cell suspension was 
filtered with a 40μm cell strainer (BD Biosciences) and the filtrate 
centrifuged at 50 x g at 4ºC for 6 minutes. Again the supernatant 
was aspirated and discarded. The pellet was resuspended in 
warm 10% serum culture media, pre-plated into a 150cm2 tissue 
culture flask, and incubated at 37ºC at 5% CO2 for 2 hours. This 
pre-plating step allowed for the removal of fibroblasts. Following 
incubation, media containing non-attached cardiomyocytes was 
aspirated and placed into a 50ml polypropylene tube. The tissue 
culture flask was rinsed gently with 10% serum culture media and 
the rinse also added to the 50ml polypropylene tube. The media 
was gently pipetted up and down once with a 25mL serological 
pipette just prior to assessing the cell density of the solution. Cells 
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were counted as described in section 2.2.2.1. Further 10% serum 
culture media was added to the cell suspension to achieve a final 
density of 7x105 cardiomyocytes/mL. At this density, a confluent 
monolayer was always achieved at 24 hours post plating. 
2.2.3.3 Post plating care of cardiomyocyte cultures 
Approximately 24hrs after plating cardiomyocytes, media was 
aspirated and the cardiomyocytes washed once with PBS pre-
warmed to 37°C. Fresh 10% serum culture media pre-warmed to 
37°C was added to the cardiomyocytes and the cells returned to 
the incubator. To prevent the growth of fibroblasts, media was 
replaced with fresh 2% serum culture media pre-warmed to 37°C 
at 48hrs and 90hrs post plating.  
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2.3 Production and Application of Lentiviral Vectors 
2.3.1 Lentiviral vector plasmids 
Third-generation, lentiviral constructs based on the human 
immunodeficiency virus Type 1 (HIV-1) were used throughout this 
research project.77-81 The plasmids included the self-inactivating 
(SIN) long terminal repeat (LTR), the central polypurine tract 
(cPPT) and the woodchuck hepatitis virus post-transcriptional 
regulatory element (WPRE). The four plasmids (see Table 2.3) 
required for vector production were kindly supplied by Professor 
Inder Verma from the Salk Institute. 
2.3.2 Vector production by lipofection 
Vector was produced by Lipofectamine 2000 reagent (Invitrogen) 
mediated lipofection of the four lentiviral plasmids into HEK293T 
cells. Seven 75 cm2 tissue culture flasks were used per vector 
production run. Cells were grown to 80% confluence and on the 
morning of transfection, media was aspirated and 10mL of fresh 
culture media added. Approximately 6 hours later, the media was 
aspirated again and replaced with the transfection mix. For each 
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75 cm2 flask of HEK293T cells, 10 mL of transfection mix 
containing a total of 40 μg of plasmid DNA was prepared. The 
DNA was made up of the 4 plasmids in equimolar ratio. The 
plasmid DNA and 75 μL of Lipofectamine 2000 reagent were 
initially incubated in 2 separate polypropylene tubes containing 
1.9 mL of Opti-MEM 1 media (Invitrogen) each, for 5 minutes at 
room temperature. Plasmid and Lipofectamine aliquots were 
subsequently mixed and co-incubated for a further 20 minutes at 
room temperature. A total of 6.2 mL of 10% DMEM/FBS was 
gently added to the plasmid/Lipofectamine mix to produce the final 
transfection mix. Approximately 16 hours later, media was 
removed from each flask and replaced with 10 mL of fresh 
DMEM/FBS media. A further 24 hours later, media was removed 
and replaced with 10 mL of fresh DMEM/FBS media. Vector-
containing supernatant was then collected 24 hours later. 
2.3.3 Vector purification and concentration 
Vector containing supernatant was purified with a 0.45 μm 
polyvinylidene fluoride (PVDF) syringe driven filter unit (Millipore) 
immediately after collection and subjected to concentration. Un-
concentrated supernatant was added to a sterile Centricon Plus-
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70 (Millipore) sample filter cup, and spun in a swing bucket 
centrifuge at 720 x g at 10 ºC for 120 minutes. The filtrate and its 
collection cup were subsequently discarded, and the device re-
centrifuged at 720 x g at 10 ºC for a further 2 minutes with a 
concentrate collection cup attached. Concentrated viral 
supernatant was divided into 50μL and 100 μL aliquots and stored 
in microcentrifuge tubes at -80 ºC. 
2.3.4 Assigning titre to vectors 
Lentiviral titre was assigned by assessing genomic DNA 
integration in transduced HEK293T cells using a quantitative 
PCR-based method as described by Sastry et al.82 
2.3.4.1 Transduction of HEK293T cells 
Suspensions of 5 x 104 HEK293T cells in 2mL of 10% 
DMEM/FCS were prepared in polypropylene tubes. Polybrene 
(Millipore) 8 μg/mL was added to enhance transduction efficiency. 
To these, 4 serial 10-fold dilutions of an initial 10μL of thawed 
concentrated vector were added in triplicate. Resulting 
suspensions were incubated at 37°C in 6-well plates for 4 days. 
Subsequent individual well cultures were washed with PBS and 
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dislodged after incubation with 100μL of 0.05% trypsin for 2 
minutes. Trypsin was deactivated with 10% DMEM/FBS and the 
cell suspensions collected in microcentrifuge tubes. Cells were 
pelleted at 300 x g for 5 minutes, and resuspended in 200μL of 
fresh PBS after decantation of the supernatant.  
2.3.4.2 Genomic DNA extraction 
Genomic DNA was isolated from the samples using a QIAamp 
DNA Mini kit (Qiagen) according to the manufacturer’s protocol. 
Qiagen Protease (20μL) was added to each sample and cell lysis 
was initiated by the addition 200μL of buffer AL. Samples were 
mixed with pulse-vortexing for 15 seconds and incubated at 56°C 
for 10 minutes. Genomic DNA was precipitated with 200μL of 
100% ethanol (Fronine) and mixed again with pulse-vortexing for 
15 seconds. The sample mixture was added to a QIAamp Mini 
spin column and centrifuged at 6000 x g at 20°C for 1 minute. The 
filtrate cup was replaced and the column was washed with 500μL 
of buffer AW1 centrifuged though at 6,000 x g at 20°C for 1 
minute. After discarding the filtrate, a second column wash was 
performed with 500μL of buffer AW2 centrifuged through at 
20,000 x g at 20°C for 3 minutes. The column was spun again at 
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20,000 x g at 20°C for a further 1 minute using a clean filtrate cup 
to ensure complete removal of buffer AW2. A total of 50μL of 
buffer AE was added to the column and allowed to incubate at 
room temperature before the genomic DNA was eluted by 
centrifugation at 6000 x g at 20°C for 1 minute. The concentration 
and purity of genomic DNA was assessed as described in section 
2.1.5. Samples were stored at -80°C. 
2.3.4.3 Real time quantitative PCR of genomic DNA 
Sequences for the lentiviral probe (5’-
FAMAGCTCTCTCGACGCAGGACTCGGC-TAMRA), forward 
primer (ACCTGAAAGCGAAAGGGAAAC), and reverse primer 
(CACCCATCTCTCTCCTTCTAGCC) were used as described by 
Sastry el al and manufactured by Sigma Aldrich.82  A total of 50ng 
of genomic DNA was used in each PCR reaction. Genomic DNA 
was diluted in 3 μL TE buffer and added to 22μL of a PCR master 
mix consisting of TaqMan buffer A (Applied Biosystems), 3.5mM 
MgCl (Applied Biosystems), 200μM of each dNTP (Applied 
Biosystems), 320nM of forward primer, 320nM of reverse primer, 
200nM of lentiviral probe and 0.025units/μL of AmpliTaq Gold 
polymerase (Applied Biosystems). For a negative template 
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control, 3μL of H20 was used. All reactions were carried out in 
triplicate and amplifications were performed with 1 cycle of 95°C 
for 10 minute, 35 cycles of 95°C for 15 seconds, and 60°C for 2 
minutes using a Rotor-Gene 6000 PCR cycler (Corbett). 
Concurrent standard curves were generated using 7 serial 10 fold 
dilutions from 108molecules/μl of the plasmid 
pRRLsin18.cPPT.CMV.eGFP.WPRE. Plasmid standards were 
spiked with genomic DNA (50ng/3μL) from non-transduced 
HEK293T cells to control for any inhibitory effect of genomic DNA 
on the PCR reactions. The number of vector DNA molecules in 
each sample reaction was calculated by comparing threshold 
cycle values of samples to the standard curve. To determine the 
final viral vector titre, the number of vector DNA molecules of each 
sample reaction was corrected for dilution and the number of cells 
plated, and then averaged.  
2.3.5 Lenti-vector transduction of primary 
cardiomyocytes 
Vector stock stored at -80 ºC was thawed rapidly in a 37 ºC water 
bath prior to transduction. Cardiomyocytes were suspended in 
media containing Polybrene 8μg/mL at the required cell density. 
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Vector stock was added at the required multiplicity of infection and 
the suspension gently pipetted once up and down with a 
serological pipette. The cell suspension was then plated and 
incubated at 37°C. Media was subsequently changed as 
described in section 2.2.3.3. Assessment of transduced 
cardiomyocytes was performed 96 hours post plating. 
2.3.6 In vivo lenti-vector mediated transduction of rat 
left atrium 
Vector stock stored at -80 ºC was thawed rapidly in a 37 ºC water 
bath prior to transduction. Following direct exposure of the left 
atrium, as per method 2.9.4, a mix of viral vector / 20% (wt/vol) 
Pluronic F127/ 0.05% Trypsin / Polybrene (160μg/mL) was 
produced, allowed to gel at room temperature, and applied to the 
left atrium with a camel hair brush as shown in Figure 2.1. Atria 
were left exposed for 20 minutes to allow viral adsorption.
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Figure 2.1: Left atrial transduction 
Transduction gel mix applied to the epicardial surface of the left atrium of 
a rat via a left thoracotomy. 
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2.4 Immunofluorescence – Staining for Connexins 
2.4.1 Antibodies for immunofluorescence 
Primary and secondary antibodies used during experiments are 
listed in table 2.4. Antibodies that required storage at -20°C were 
divided into 10μL aliquots using microcentrifuge tubes to minimise 
freeze-thaw cycles. 
2.4.2 Atrial tissue sectioning 
All cryo-sectioning was performed with a Microm HM 505E 
microtome cryostat. The temperature of the cooling chamber was 
always set to -21°C prior to the commencement of tissue 
handling. Frozen atrial tissue embedded in OCT compound 
(obtained as detailed in section 2.9.5) were mounted on a cryostat 
chuck pre-cooled with dry ice, and placed on the cryostat arm. A 
fresh microtome knife was used to initially trim the specimen, and 
then cut 7μm sections of atria that were transferred to glass slides 
(Superfrost Ultra Plus; Thermo Scientific) and kept on dry ice.  
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Table 2.4: Immunofluorescence Antibodies 
 
Primary Ab Specificity Host Species Source Dilution 
Connexin40 
Rabbit, 
polyclonal 
Millipore 1 in 1000 
Connexin43 
Mouse, 
monoclonal 
Millipore 1 in 250 
Secondary 
Ab 
Specificity 
Fluorophore    
Mouse Fc Alexa Fluor 488 
Goat, F(ab’)2 
fragment 
Invitrogen 1 in 1000 
Rabbit Fc Alexa Fluor 594 
Goat, F(ab’)2 
fragment 
Invitrogen 1 in 2000 
Mouse Fc Alexa Fluor 594 
Goat, F(ab’)2 
fragment 
Invitrogen 1 in 2000 
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2.4.3 Fixation, permeabilisation and immunostaining 
Atrial tissue sections and cell cultures were fixed, permeabilised 
and immunostained using the same method. Samples were fixed 
with 4% (w/v) paraformaldehyde for 15 minutes at room 
temperature and then washed 3 times with PBS. As the primary 
antibody epitopes were intracellular antigens, samples were then 
subject to permeabilisation by with 0.1% (v/v) Triton X-100 
(Sigma-Aldrich) in PBS for 15 minutes followed by 3 gentle 
washes with 0.05% (v/v) Tween 20 (Sigma-Aldrich) in PBS 
(PBST) for 5 minutes each on an orbital shaker. A blocking 
solution consisting of 2% goat serum and 0.1% cold fish skin 
gelatine in PBST was applied for 1 hour. Samples were then 
incubated with primary antibody diluted in blocking solution 
overnight at 4°C. The following morning, samples were washed 
gently 3 times with PBST for 5 minutes each on an orbital shaker. 
Secondary antibody, diluted with 0.1% (v/v) cold fish skin gelatine 
in PBST, was added to samples for 1 hour at room temperature in 
the dark, followed by 3 gentle washes with PBST for 5 minutes 
each on an orbital shaker in the dark. Samples were cover slipped 
(Deckgläser; Menzel-Gläser) mounted with Prolong Gold anti-fade 
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reagent with DAPI (Life Technologies) and allowed to set in the 
dark, overnight at 4°C. 
2.4.4 Fluorescent image acquisition and processing 
Imaging of slides was performed under oil immersion using either 
an upright wide field fluorescent microscope (Leica DMBL) with a 
100X objective (Leica 100X/1.30 Oil FLUOTAR 506195) or a 
confocal laser scanning microscope (Olympus FV 1000) using a 
60X objective (Olympus 60X/1.35/0.15 (WD) Oil UPLSAPO). 
Imaging of cultures was performed using an inverted wide field 
fluorescent microscope (Leica DMIL) with a 20X objective (Leica 
20X/0.305 Ph1 ן/0.2 506272 HI plan 1). Digital images from the 
Leica DMBL microscope were acquired into PC based software 
(Spot Advanced version 4.1) using a digital camera (Spot RT KE) 
fitted to the microscope. Digital images from the confocal 
microscope were directly acquired into PC based software 
(Olympus FV10-ASW Version 1.7). Digital images from the Leica 
DMIL microscope were acquired into PC based software (Leica 
Application Suite Vesion 2.6.0 R1) using a digital camera (Leica 
DFC 490) fitted to the microscope.  
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Table 2.5: Filter Sets for Leica DMIL Microscope 
 
Filter Sets Exciter (nm) Emitter (nm) 
DAPI 315 - 420 385 - 515 
GFP 430 - 510 475 - 575 
DsRed 480 - 570 565 ALP 
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Table 2.6: Excitation Wavelengths and Emission Filter Sets 
for the Olympus Confocal Microscope 
 
Filter Sets Excitation (nm) Emission (nm) 
WU2 BP 330 -  385 BA 420 
NIBA3 BP 470 - 495 BA 510 - 550 
WIG3 BP 530 - 550 BA 575 IF 
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2.5 Histology – Inflammation and Fibrosis 
2.5.1 Inflammation - Haematoxylin and Eosin staining 
Fresh atrial tissue sections were produced as described in 
sections 2.4.2 and 2.9.5. The technique of Haematoxylin and 
Eosin staining as described by Luna et al was performed with a 
Shandon Linear Stainer. Atrial sections were immersed in 
Haematoxylin for a total of 4 minutes, Scott’s Bluing solution for 1 
minute, and 0.1% Eosin for 1 minute. A 1 minute wash with tap 
water was performed following each step. Prior to coverslip 
mounting with a hydrophobic mounting agent, Ultramount No4 
with colourfast (Fronine), samples were dehydrated with absolute 
ethanol for 30 seconds and placed in xylene clearing solution. 
Slides were allowed to set overnight. Following image acquisition 
as described in section 2.5.3, images were assessed manually for 
inflammation by two independent observers. The technique 
described by Igarashi et al was used to grade inflammation on a 
scale of 1 to 5. Images were assigned a score of 1 if inflammation 
was not present, a score of 2 if occasionally present, a score of 3 
if diffusely affecting less than 50% of the image, a score of 4 if 
diffusely present throughout more than 50% of the image, and a 
score of 5 if near complete presence in the entire image. 
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2.5.2 Fibrosis - Picro-Sirius Red staining 
Atrial tissue sections produced as described in section 2.4.2 were 
fixed with 4% paraformaldehyde for 15 minutes followed by 3 
washes in PBS for 5 minutes. Sections were placed in Picro-Sirius 
red solution (0.1% Direct Red 80 (Sigma), 0.1% Fast Green FCF 
(Sigma), Saturated Picric Acid (Sigma)) for 1 hour in the dark on 
an orbital shaker set to 50rpm. One wash with MQH20 was 
performed followed by 3 washes in 100% ethanol for 1 minute 
each to dehydrate the sections. Samples were allowed to air dry 
for 1 hour and then immersed in xylene clearing solution for 5 
seconds before cover slip mounting with a hydrophobic mounting 
agent, Ultramount No4 with colourfast (Fronine). Slides were 
allowed to set overnight. Sections were then processed with 
custom made software designed to objectively calculate the 
relative areas of red (collagen) and green staining (myocytes). 
2.5.3 Image acquisition and processing 
Samples were visualised initially using an upright microscope 
(Leica DMBL). A 20X objective (Leica 20X/0.40 N plan ן /0.17/D 
506096) was used for image acquisition of 8 random areas of 
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each section under oil immersion. The PC based software, Spot 
Advanced version 4.1, was used to directly acquire digital images 
from a Spot RT KE camera fitted to the microscope.  
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2.6 Immunoblotting  
2.6.1 Antibodies for immunoblotting 
Primary antibodies used during experiments are listed in table 2.4. 
Secondary antibodies used during experiments are listed in table 
2.7. Antibodies that required storage at -20°C were divided into 
10μL aliquots using microcentrifuge tubes to minimise freeze-thaw 
cycles. 
2.6.2 Protein extraction 
Cell culture 
Six well plates with confluent cells were place on ice. A 50μl mix 
of ice cold lysis solution (RIPA buffer (Sigma-Aldrich), 1% 
phosphatase inhibitor cocktail 2 (Sigma-Aldrich), and 4% protease 
inhibitor cocktail (Sigma-Aldrich)) was added to each well. Cells 
were dislodged from the plate surface with a plastic scraper. The 
resulting suspension was placed in ice cold microcentrifuge tubes 
and incubated on ice for 30 minutes. Suspensions were then 
centrifuged at 300 x g for 5 minute at 4°C. The supernatant 
decanted into a second ice cold microcentrifuge tube and kept on 
ice ready for protein estimation.  
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Table 2.7: Secondary antibodies for immunoblotting 
Secondary Ab 
Specificity 
Label Host 
Species 
Source Dilution 
Mouse Fc HRP Rabbit Sigma 1 in 10000 
Rabbit Fc HRP Goat Sigma 1 in 10000 
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Atrial Tissue 
Frozen atrial tissue was placed into an ice cold round bottom 
microcentrifuge tube and kept on ice. An ice cold steel ball 
(Qiagen) was inserted into the tube along with 300μl of ice cold 
lysis solution (RIPA buffer (Sigma-Aldrich), 1% (v/v) phosphatase 
inhibitor cocktail 2 (Sigma-Aldrich), and 4% (v/v) protease inhibitor 
cocktail (Sigma-Aldrich)). The tissue was then subjected to 
disruption with bead milling for 4 minutes using a TissueLyser 
(Qiagen) set to 20Hz.  Suspensions were then centrifuged at 300 
x g for 5 minute at 4°C. The supernatant was decanted into a 
second ice cold microcentrifuge tube and kept on ice ready for 
protein estimation. 
2.6.3 Protein estimation 
Protein estimation was performed using the Bradford method. All 
standards and samples were assayed in triplicate. Bovine serum 
albumin (1mg/mL) was added, in 1mL increments from 1mL to 
10mL, to different wells of a 96 well plate, and used to generate a 
standard curve. Extracted protein samples were diluted 10 fold 
with MQH20 and added to wells in quantities of either 1μL or 2μL. 
Protein assay dye reagent concentrate (Bio-Rad) was diluted 4 
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fold and added in 200μL quantities to each well. The absorbance 
at a wavelength of 595nm was then measured for each well using 
a Victor2 Multilabel Counter (PerkinElmer life Sciences). The 
amount of protein added to each sample well was calculated by 
comparing its absorbance to the standard curve. To determine the 
original protein concentration of an individual lysis supernatant, 
the protein amount within each well corresponding to the 
respective supernatant sample was corrected for dilution and then 
averaged. 
2.6.4 Immunoblotting 
Precast polyacrylamide 4-12% gradient Bis-Tris gels (NuPAGE; 
Invitrogen) were placed in a gel electrophoresis chamber (XCell 
SureLock Min-Cell; Invitrogen) containing running buffer (MOPS, 
NuPAGE; Invitrogen). For each sample, 20mg of protein was 
diluted in a microcentrifuge tube to a final volume of 20μL with 
2μL of reducing agent (NuPAGE; Invitrogen), 5μL of LDS sample 
buffer (NuPAGE; Invitrogen), and MQH20. Diluted samples were 
heated to 95°C for 10 minutes to denature proteins and then 
loaded into separate gel wells. A constant 200V current gradient 
was applied to the gel for 1 hour. A pre-stained protein ladder 
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(PageRuler Plus; Thermo Scientific) was used to assess protein 
separation and approximate protein sizes. Following 
electrophoretic separation, protein was transferred from the gels 
to a membrane using the IBLOT gel transfer system (Invitrogen). 
Gels were placed in a gel transfer stack (Invitrogen) and the 
IBLOT’s default 7 minute transfer protocol was used. Membranes 
were subsequently blocked with a solution of 5% skim milk in 
TBST (0.05% Tween 20, Tris-Buffered Saline) for 1 hour. 
Membranes were then incubated with primary antibody diluted in 
blocking solution, with gentle agitation on an orbital shaker, 
overnight at 4°C. The following morning, membranes were 
washed 3 times in TBST for 5 minutes each, and incubated with 
secondary antibody diluted in blocking solution for 1 hour, with 
gentle agitation on an orbital shaker. Three TBST washes for 5 
minutes each was performed again followed by 5 minutes of 
incubation with Amersham ECL Western blotting detection 
reagents, which had been mixed in a 1 to 1 ratio according to the 
manufacturer’s instructions. Membranes were transferred to an 
autoradiography cassette (Hypercassette; Amersham 
Biosciences). In a dark room, chemiluminescence film (Hyperfilm 
ECL; Amersham) was exposed to the protein membranes in the 
autoradiography cassette. The time of exposure was dependant 
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on the demands of the experiment. Following exposure, film was 
processed with an AGFA film processor according to the 
manufacturer’s protocol. 
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2.7 Quantification of Tissue Connexin mRNA 
2.7.1 mRNA extraction and purification  
mRNA extraction was performed using an RNAeasy Mini Kit 
(Qiagen) according to the manufacturers protocol. Atrial tissue 
was transferred frozen to an ice cold round bottom 
microcentrifuge tube. A stainless steel bead (Qiagen), along with 
350μL of buffer RTL (Qiagen), was placed within the 
microcentrifuge tube. The tissue was then subjected to 
simultaneous disruption and homogenisation with bead milling for 
4 minutes using a TissueLyser (Qiagen) set to 20Hz. Following 
milling, the lysate was centrifuged at 20,000 x g for 3 minutes at 
21°C. All subsequent centrifugation steps were performed at 
8,000 x g at 21°C. The supernatant was carefully aspirated and 
placed in a fresh microcentrifuge tube. A 450μL volume of 70% 
ethanol was added to the supernatant and mixed with pipetting. 
The resulting solution was transferred to an RNAeasy spin column 
in 2 successive 450μL aliquots which were centrifuged for 15 
seconds each. The column was washed using 700μL of buffer 
RW1 with centrifugation for 15 seconds. The column was then 
washed twice using 500μL of buffer RPE, with centrifugation for 
15 seconds for the first wash and 2 minutes for the second wash. 
107 
 
The RNAeasy spin column was then centrifuged for 1 minute 
using a new collection tube to eliminate any possible carryover of 
buffer RPE. The RNAeasy spin column was transferred again to a 
new collection tube. A 30μL volume of RNase-free water was 
added to the column and used to elute the RNA with 
centrifugation for 1 minute. RNA samples were placed on ice. 
RNA concentration and purity was assessed with 
spectrophotometry as described in section 2.1.5, however with the 
assumption that 40μg of mRNA had an absorbance of 1.0 at 
260nm and pure mRNA had a 260/280 absorbance ratio of 1.8. 
2.7.2 cDNA synthesis from mRNA 
mRNA was converted to cDNA  with a Moloney Murine 
Leukaemia Virus Reverse Transcriptase (M-ML VRT) first-strand 
synthesis system (Promega). A mix containing 2μg of mRNA and 
0.5 μg of random primers (Invitrogen) was diluted to 10 μL using 
DEPC-treated water. The RNA/primer mixture was incubated at 
70°C for 5 minutes to melt secondary template structures and 
then placed on ice. Following incubation, a reaction mix consisting 
of 5 μL M-MLV 5X reaction buffer, 1.25 μL of each dNTP, 25 Units 
of Recombinant RNasin Ribonuclease Inhibitor, and 200 Units of 
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M-MLV RT was added to the RNA/primer mixture and diluted with 
DEPC-treated water to a final volume of 25 μL. The resultant 
mixture was gently flicked and incubated at 42°C for 60 minutes. 
The reaction was then terminated with 5 minutes incubation at 
70°C. The sample was placed on ice ready for cDNA 
concentration assessment as described in section 2.1.5.  
2.7.3 Real time quantitative PCR 
The Cx43 forward and reverse primer sequences were 
AGCCTGAACTCTCATTTTTCCTT and 
CCATGTCTGGGCACCTCT respectively. The Cx40 forward and 
reverse primer sequences were CAGAGCCTGAAGAAGCCAAC 
and CATCTTGCCAAGTGTTGGAG respectively. The GAPDH 
forward and reverse primer sequences were 
TGGGAAGCTGGTCATCAAC and GCATCACCCCATTTGATGTT 
respectively. A total of 8μL of cDNA, 10μM primers (0.75uL), 2X 
Sybr min (10μL), and water (0.5μL) were used in each PCR 
reaction. All reactions were carried out in triplicate and 
amplifications were performed with 1 cycle of 50°C for 2 minutes, 
1 cycle of 95°C for 2 minutes, and 40 cycles of 95°C for 15 
seconds alternated with 60°C for 45 seconds, using a Rotor-Gene 
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6000 PCR cycler (Corbett). Results for each triplicate were 
averaged. Connexin RNA levels were normalised to GAPDH. 
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2.8 Primary Cardiomyocyte Electrophysiology 
2.8.1 The multi-electrode array 
Custom made multi-electrode arrays (MEA) were obtained from 2 
sources as shown in Figure 2.2. The first, obtained from the 
Institute of Microtechnology (IMT; University of Neuchâtel, 
Switzerland), utilised a PECVD silicon nitride passivated glass 
chip with platinum electrodes that was mounted onto an open 
PCB with epoxy. The usable transparent area was delimited by a 
glass ring with an internal diameter of 20mm which formed the 
walls of the culture well. Recoding electrodes had a diameter of 
60μm and a centre to centre inter-electrode distance of 500μm. 
The second manufactured by Lowe Electronics Limited (China) 
using conventional printed circuit board (PCB) technology. Its 
surface consisted of polyimide, and electrodes were gold plated. 
The usable semi-transparent area was delimited by a Perspex 
(poly-methyl-methacrylate) ring with an internal diameter of 16mm 
which formed the walls of the culture well. Recoding electrodes 
had a diameter of 75μm and a centre to centre inter-electrode 
distance of 700μm. Two stimulation electrodes with an inter-
electrode (stimulation to stimulation and stimulation to recording) 
distance of 1000μm were placed on each of the 4 sides of the 
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recording array of both MEA’s. Both MEA’s possessed 52 
recording electrodes and 8 stimulation electrodes 
2.8.2 Culture recording 
Multi-electrode arrays containing cardiomyocyte cultures were 
mounted into a commercial recording stage fitted internally with an 
amplifier (MEA1060 Amplifier; Multichannel Systems) as shown in 
Figure 2.3. After amplification, the electrical activity of cultures 
detected by the 52 recording electrodes were simultaneously 
digitised at 10kHz with a PXI platform (National Instruments), 
transferred to a PC based laptop computer (Dell) via an express 
card (NI ExpressCard-8360; National Instruments), and recorded 
using LabView (Version 10.0.1; National Instruments) as shown in 
Figure 2.4. Data was processed using the commercially available 
software CEPAS (Cuoretech). 
2.8.3 Culture stimulation  
An isolated pulse stimulator (Model 2100; A-M Systems) was 
used to deliver constant current stimuli at a frequency of 2Hz to 
cardiomyocyte cultures. Cultures grown on MEA’s sourced from 
. 
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IMT were stimulated by the stimulating electrodes incorporated 
into the array and required approximately 50μA for cardiomyocyte 
capture. Due to the capacitance properties of the polyimide 
MEA’s, stimulation was performed via a separate custom made 
bipolar electrode device which when fitted to the top of culture 
wells, placed its electrodes in close proximity to the culture. This 
method required approximately 200μA for cardiomyocyte capture. 
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2.9 In Vivo Studies 
2.9.1 Anaesthesia, intubation, ventilation, and 
positioning 
Rats were anesthetised in a custom made Perspex chamber with 
a mix of oxygen and 5% isoflurane (Aerrane; Baxter Healthcare) 
supplied via flexible PVC tubing from a small animal anaesthetic 
machine (The Stinger; Advanced Anaesthesia Specialists). Once 
unconscious, rats were positioned, dorsal surface downwards, on 
a custom made intubation board shaped to facilitate neck 
extension. Direct laryngoscopy was performed by pulling the 
tongue out with straight serrated forceps (Fine Science Tools) and 
passing a rigid hippocampal tool (Fine Science Tools) into the 
pharynx to support the anterior neck tissues. The tubing of an 18 
gauge intravenous cannula (Becton, Dickinson and Company) 
was passed under direct vision between the vocal cords into the 
trachea using a Seldinger technique. Rats were transferred to a 
bread board (Ikea) with their dorsal surface downwards. The 
cannula was subsequently attached with flexible PVC tubing to a 
small animal ventilator (Harvard Apparatus) set to deliver 2.5 ml 
tidal volumes at a rate of 70 breaths per minute. The ventilator 
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received a mix of oxygen and 2% isoflurane from the small animal 
anaesthetic machine (The Stinger; Advanced Anaesthesia 
Specialists). Prior to electrophysiology studies and thoracic 
surgery, upper and lower limbs were held fixed, extended at the 
shoulders and hips, by rubber bands looped around hooks 
screwed into the bread board. 
2.9.2 Surface electrocardiography 
When rats were anaesthetised, unipolar needle electrodes (AD 
Instruments) were placed subcutaneously at the infra-clavicular 
and iliac fossa regions bilaterally. Two lead electrocardiograms 
were generated combining potentials from left upper / right lower 
and right upper / left lower electrodes pairs. Bio-potentials, 
sampled at 2 kHz, were amplified with an Octal Bio Amp (AD 
Instruments) and digitised using a Powerlab 16/30 (AD 
Instruments) data acquisition system. Data was recorded, via 
USB, using the Windows based version of Labchart Pro 7 (AD 
Instruments) running on a Dell laptop. No software filtering was 
used. All data was analysed in detail offline. 
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2.9.3 Trans-oesophageal cardiac stimulation and 
recording 
A 5 French octapolar catheter (Biosense Webster) connected to 
the Octal Bio Amp was passed via the oral cavity into the 
oesophagus and positioned at the point where recordings from the 
distal 2 electrodes had the largest atrial electrograms amplitudes. 
Recordings were made from the distal 2 electrodes only, while 
stimulation was delivered through the proximal 2 electrodes only. 
Atria were captured using a constant 60 volt square shaped 
stimulus of 1 millisecond duration via an isolated pulse stimulator 
(Model 2100; A-M Systems). Custom designed software installed 
on a second windows based laptop (Acer) was used to drive the 
stimulator via its trigger input. 
The electrophysiology protocol involved the assessment of atrial 
refractory periods followed by an attempt to induce atrial fibrillation 
(AF). Atrial refractory periods were assessed using a drive train of 
8 stimuli at a coupling interval of 150ms followed by 1 extra-
stimulus. The coupling interval between the drive train and the 
extra-stimulus started at 120ms and was progressively reduced in 
10ms increments down to atrial refractoriness. AF induction was 
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performed using a single burst of atrial pacing with a 90ms 
coupling interval for 5 seconds.  
2.9.4 Thoracic surgery 
A total of 10μg of Buprenorphine hydrochloride (Temgesic; 
Schering-Plough) and 1mg enrofloxacin (Baytril 50; Bayer 
Healthcare AG) were separately diluted in 1ml of PBS each and 
administered subcutaneously by injection. The hair of the anterior 
chest was moistened with 70% (v/v) ethanol (Fronine), shaved 
with electric clippers (Remington; Spectrum Brands), and 
removed. Skin disinfection was performed with 10% w/v Povidine-
Iodine solution (Betadine; Sanofi-Aventis) applied for a minimum 
of 5 minutes prior to skin incision. 
Using a scalpel, a horizontal incision of the skin from the ventral 
midline to the left anterior axillary line was made at the level at 
which the left apical beat was most prominent to palpation. Blunt 
dissection with straight haemostats (Fine Science Tools) of the 
underlying superficial fascia for up to approximately 1cm on both 
sides of the incision was performed to mobilise the surrounding 
skin. The muscles of the left chest wall superficial to the ribs and 
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overlying the area of the left atrial beat were also separated by 
blunt dissection with straight haemostats (Fine Science Tools). 
Using curved haemostats (Fine Science Tools), the thoracic cavity 
was punctured via the intercostal space lying over the area of the 
left atrial beat. The punctured intercostal muscles were blunt 
dissected with the same curved haemostats and a Castroviejo 
retractor (Roboz) was inserted to hold open the dissected 
intercostal space. A hole was made in the pericardial sac over the 
left atrium with curved forceps (Fine Science Tools). Viral vector 
was applied to the left atrium as described in section 2.3.5. 
Following viral application and adsorption, the retractor was 
removed and the rib space closed with a single stitch of 3.0 
coated vicryl suture (Ethicon). The skin incision was then closed 
with a horizontal mattress technique using a 3.0 coated vicryl 
suture (Ethicon). Drinking water for rats was supplemented with 
0.01% enrofloxacin (Baytril 25; Bayer Healthcare AG). 
2.9.5 Atrial tissue extraction, preparation, and storage 
Prior to atrial extraction, adult rats were euthanized with carbon 
dioxide in a custom made Perspex chamber for 10 minutes and 
then weighed. Rat were subsequently laid dorsal surface down 
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and the chest wall cut open with scissors to the right of the 
midline. The heart was detached from the mediastinum just above 
the base and rinsed with PBS and subsequently weighed. The left 
atrium was then separated from the rest of the heart with a pair of 
fine scissors and rinsed once with PBS. For histology and 
immunohistochemistry studies, atria were placed in a vinyl 
specimen mould (Cryomold; Sakura) filled with Tissue-Tek OCT 
compound (Sakura). The mould was then frozen with liquid 
nitrogen and transferred to a -80°C freezer for storage. For protein 
and mRNA studies, atria were placed in microcentrifuge tubes, 
frozen in liquid nitrogen and transferred to a -80°C freezer for 
storage.  
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2.10 Statistics 
Required sample sizes were estimated using nQuery Advisor 
(Statistical Solutions).  
In the entailing in vivo research, we wished to detect a mean shift 
of 2 standard deviations or more in the transduced groups from 
the mean value observed in the control group. This was 
equivalent to requiring an effect size of 2 or more due to 
transduction. In order to detect an effect size of 2 with 80% power, 
a sample size of 6 per group was required (two sample t-test, 5% 
significance level, two tailed tests).   
Our study of cardiomyocyte cultures required the measurement of 
conduction velocities on an MEA. Previously, the mean 
conduction velocity in non-transduced NRVM cultures was 
measured to be 19.1cm with a standard deviation of 0.6cm/s.83 
We expected that the connexin40 mutations would reduce mean 
conduction velocity to at least 16cm/s with a standard deviation of 
0.6cm/s. Hence, a sample size of 6 cultures in each group will 
have over 80% power to detect a difference in means of 2.0cm/s 
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assuming that the common standard deviation is 0.6cm/s using a 
two group t-test with a 0.05 two sided significance level.  
Each experimental group obtained equal subject numbers 
(randomly assigned) from multiple litters in order to minimise the 
effect of variance between the measurement means of single 
litters. 
All data obtained is expressed as means +/- standard deviation 
and was assessed using PSAW Statistics 18. Parametric data 
was analysed with t-tests while non-parametric data (AF 
durations) were analysed with Mann-Whitney tests. Each mutant 
study group was compared to the wtCx40 study group. 
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CHAPTER 3 
 
A System for Assessment of Lentivector Gene 
Modified Primary Cardiomyocytes 
 
3.1 Introduction and Aims 
Despite significant limitations, in vitro patch clamp techniques and 
in vivo genetically engineered animal models are the main 
techniques currently utilised by leading institutions for the 
functional screening of novel gene mutations identified in patients 
with cardiac arrhythmias.  
While patch clamping is useful for studying action potential 
characteristics, contradictory results have been obtained 
depending on the cell type studied. Furthermore, single/dual cell 
studies fail to consider the modulating effects of extracellular 
signals often found in a multi-cellular syncytium. Genetically 
engineered animal models are useful for overcoming these 
limitations, but are however limited due to secondary 
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developmental defects. The classic example is the high incidence 
of congenital malformations associated with alterations in 
connexin expression.34-36 Both techniques are further hampered 
by high costs and a need for intensive training, experience, and 
time.  
With the above mentioned limitations in mind, electrical 
assessment of acutely altered, genetically modified cardiomyocyte 
monolayers presents itself as an attractive alternative for studying 
such mutations. To date, numerous studies have assessed the 
effects of lentivector gene modification of cardiomyocyte 
monolayers with optical mapping, specifically looking at far field 
potential characteristics, automaticity, and conduction velocities. 
While extremely effective, optical mapping systems require 
significant technical support, a large capital investment, and 
darkroom workspace. 
The multi-electrode array system has also been widely employed 
to assess the properties of cardiomyocyte monolayers. Most 
notably, using a variety of myocyte origins including atrial cell 
lines, stem cell derived myocytes, and neonatal rat ventricular 
myocytes, multi-electrode arrays have been used as a tool for 
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drug evaluation. Importantly this system is less hampered by the 
investment limitations of an optical mapping system.  
The aim of this study was to validate the ability of a multi-
electrode array (MEA) system for studying lentivector gene 
modified primary cardiomyocytes. We hypothesised that 
alterations in ion channel expression in primary cardiomyocytes 
alters monolayer conduction velocities (CV) in a predictable way 
on an MEA system. 
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3.2 Methods 
3.2.1 Vector packaging and titration 
Vector stocks encoding eGFP, the connexin43 internal loop 
mutant CX43Δ8, and the rat inward-rectifier potassium ion 
channel 2.1 (Kir2.1) were produced using the four plasmid 
lipofection method as described in sections 2.3.1 to 2.3.3. Titre 
was assigned to vector stocks by assessing genomic integration 
of viral DNA following transduction of HEK293T cells as described 
in section 2.3.4.   
3.2.2 Myocyte isolation, transduction and culture 
Neonatal rat ventricular myocytes were isolated from 2 to 3 day 
old Sprague Dawley rat pups as described in section 2.2.3. After 
isolation, myocytes were separated into a maximum of 4 study 
groups using 50 ml polypropylene tubes as shown in figure 3.1. 
Vector transduction of myocytes in suspension at equal 
multiplicities of infection was performed in the presence of 
Polybrene 8μg/mL as described in section 2.3.5. The non-
transduced group received only Polybrene 8μg/mL. Following 
transduction, myocytes were seeded at a density of 220 x 103 
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cells/ cm2 onto either polystyrene, multi-well plates for 
transduction optimisation, or onto glass multi-electrode arrays for 
assessment of myocyte monolayer electrophysiology. 
3.2.3 Transduction optimisation 
To assess transduction efficiencies and toxicity, bright field and 
fluorescence microscopic assessment at a magnification of 20X 
was performed of cultures plated onto polystyrene plates after 
eGFP transduction at multiplicities of infection (MOI) of 1, 5, 25, 
50, and 75. The capture ability of cultures to stimulation with 30μA 
pulses of 1ms duration at differing MOI’s was also assessed. 
3.2.4 Multi-electrode array studies 
Transduced eGFP control monolayers were initially assessed for 
their level of transduction. If transduction efficiency was lower than 
95% in any culture, all cultures within the experiment were 
discarded and section 3.2.2 repeated. If fluorescent assessment 
was satisfactory, all monolayers were next assessed for 
confluency with bright field microscopy. All non-confluent cultures 
were discarded, prior to electrophysiological assessment.  
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Following placement of MEA’s within the MEA stage, MEA culture 
wells were sealed with a coverslip and the culture temperature 
maintained at 37°C for a minimum of 5 minutes prior to further 
assessment. Spontaneous beating frequency was assessed with 
bright field microscopy. If the beat frequency of an individual 
culture was greater than 2Hz, the culture was discarded. 
Conduction velocity assessment was then performed as described 
in sections 2.8.1 to 2.8.3. In brief, all remaining cultures were 
stimulated with square shaped 30μA current pulses of 1ms 
duration at a frequency of 2 Hz. Monolayer capture was assessed 
with bright field microscopy, followed by recording of monolayer 
field potentials via the multi-electrode array system. The software 
CEPAS was then used to generate isochronal maps of each 
culture and calculate the velocity of far field potential propagation. 
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Figure 3.1: NRVM’s study flow diagram.  (NT - Non-
transduced)  
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3.3 Results 
3.3.1 Optimal multiplicity of infections 
Bright field and fluorescent micrographs taken approximately 96 
hours  following plating of NRVM’s after transduction at 
multiplicities of infection of 1, 5, 25, 50, and 75 are shown in figure 
3.2. Transduction efficiency falls below 95% at an MOI of 1. At all 
higher MOI’s, transduction efficiency remains above 95% by 
visual inspection. At these levels of transduction, culture 
confluency remains at 100%, and by visual inspection, there was 
no visible toxicity due to the level of virus transduced or eGFP 
expressed. 
3.3.2 Culture capturability 
As shown in table 3.1, at least half of all eGFP transduced 
cultures were captured at all MOI’s tested. Beat frequency was 
however higher than non-transduced controls at MOI’s of 100 and 
75, indicating toxicity from either virus or eGFP. Monolayers 
belonging to the CX43Δ8 group failed to capture at MOI’s above 
25. In addition, non-coordinated spontaneous contractions of  
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myocytes with a fibrillatory appearance were observed at these 
higher MOI’s. Taking the results of the eGFP and CX43Δ8 groups 
into consideration, monolayers belonging to the KIR2.1 group 
were subsequently assessed only at an MOI of 25. All cultures 
within this group possessed a beat frequency less than 1Hz, and 
were captured when stimulated. Figure 3.3 demonstrates a 
transduction efficiency of greater than 95% in monolayers 
transduced with eGFP at a multiplicity of infection of 25 along with 
a good far field potential detected during stimulation. Hence all 
subsequent conduction velocity assessments were performed at 
an MOI of 25. 
3.3.3 Isochronal maps and conduction velocities 
Isochronal maps, which represent the distance travelled by a 
propagating action potential wave front over fixed time intervals, 
were generated for each monolayer. In cultures with a slower than 
usual conduction velocity, less distance is travelled during each 
consecutive isochrone and hence isochronal narrowing or 
crowding is observed. The opposite is observed in monolayers 
with faster than usual conduction velocities where isochrones are 
wider due to the greater distance travelled during a fixed time 
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interval. Figure 3.4 demonstrates representative isochronal maps 
from each of the 4 study groups. Isochrones of the non-
transduced map are generally equal in width and the mean 
conduction velocity for the group is 22.0 ± 1.1 cm/s. Compared to 
non-transduced cultures, the eGFP group possessed mildly 
narrower isochrones and this translated to a mildly slower mean 
group conduction velocity of 19.3 ± 1.7 cm/s. Compared to both 
the non-transduced and eGFP groups, the KIR2.1 group 
possessed markedly wider isochrones with a much faster mean 
group conduction velocity of 27.6 ± 1.2 cm/s. The CX43Δ8 group 
possessed marked crowding of isochrones compared to all other 
groups with a mean group conduction velocity of 8.0 ± 3.5 cm/s. 
Mean conduction velocities of all transduced groups were 
significantly different compared to non-transduced monolayers as 
shown in figure 3.5 and the direction and magnitude of conduction 
velocity changes were consistent with the results of published 
optical mapping studies. 
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Figure 3.3: eGFP fluorescence of an NRVM monolayer on an 
MEA 
Greater than 95% transduction was achieved at an MOI of 25. 
The insert (bottom left corner) demonstrates good amplitude of a 
far field potential detected at electrode 25 during stimulation.  
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Figure 3.4: Representative Isochronal maps 
Representative isochronal maps and mean conduction velocities 
of each of the 4 study groups. 
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Figure 3.5: Graphical representation of mean conduction 
velocities.  
Conduction velocities of all transduced groups are significantly 
different to non-transduced controls. 
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3.4 Discussion 
These results demonstrate that the multi-electrode array system is 
a reliable method for studying lentivector gene modified primary 
cardiomyocytes. In particular, transduction of monolayers to 
express eGFP, KIR2.1, or CX43∆8 resulted in predictable 
changes in conduction velocity when measured on an MEA. 
Hence the multi-electrode array system would be a useful tool to 
study the functional significance of disease related gene 
mutations. 
3.4.1 Assessing conduction velocities and 
capturability 
Propagation velocity is determined by the rate of passive transfer 
of ions between both zones. This in turn is determined by drivers 
of passive ion transfer and resistors to this process. The main 
drivers are action potential amplitude and speed of action 
potential generation which is determined by fast sodium channels 
(INa rapid current). The main resistors are intra-cellular 
cytoplasmic resistance and inter-cellular gap junction resistance. 
140 
 
The resistance of the central aqueous pore of cell-cell coupled 
connexons is inversely proportional to its conductance capacity.18  
3.4.1.1 Characteristics of KIR2.1 over expression 
While the channel Kir2.1 is predominately responsible for the late 
phase of action potential repolarisation, studies have 
demonstrated that over expression not only shortens action 
potential duration but also increases sodium channel availability.84 
Hence over expression is expected to increase myocyte 
conduction velocities, a phenomenon that has previously been 
demonstrated with optical mapping of lentivector modified 
cardiomyocyte monolayers.83  
3.4.1.2 Characteristics of CX43∆8 over expression 
The connexin43 loop mutant CX43∆8 has been shown to exert a 
dominant negative effect on endogenous connexin43 (Cx43) in 
myocytes resulting in slowing of myocyte conduction when 
assessed with optical mapping.85 In addition, we have shown that 
at a multiplicity of infection of 50, CX43∆8 is capable of 
precipitating a degree of cardiomyocyte uncoupling supportive of 
fibrillatory type contractile activity in monolayers. This effect was 
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not observed within the eGFP group at the same MOI level 
suggesting that the disorganised contraction is secondary to 
endogenous connexin interference rather than viral toxicity. A pro-
arrhythmic effect of the CX43∆8 was also observed by Nakagami 
et al., where rapid pacing of NRVM cultures transduced with 
CX43Δ8 produced spiral wave re-entrant arrhythmias.86  
3.4.1.3 Characteristics of eGFP over expression 
An expected mild slowing of conduction secondary to eGFP 
expression was observed, the degree of which is consistent with 
prior optical mapping data.83 Although the mechanism for slowing 
has yet to be elucidated, existing studies point towards both an 
interference effect on connexin expression and a reduction in 
sodium channel availability, possibly through an alteration in the 
levels of repolarising ion channels. 
3.4.2 Implications of these findings 
With the advent of genome wide sequencing, and the rapid 
identification of novel gene mutations, there is a clear need for 
inexpensive high throughput functional screening to delineate 
between functionally significant mutations and simple 
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polymorphisms. Our study clearly demonstrates that the multi-
electrode array system is able to accurately assess the functional 
effects of lentivector gene modified cardiomyocyte monolayers.  
Our results in combination with the recent development of cheap 
disposable polyimide based multi-electrode arrays using printable 
circuit board technology ideally positions the MEA system as a 
diagnostic tool suitable for the functional screening of mutations 
within myocytes. 
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CHAPTER 4 
 
The Human Connexin40 Mutations P88S, G38A, 
and A96S Alter Primary Cardiomyocyte 
Coupling and Conduction 
 
4.1 Introduction and Aims 
Germ-line (A96S) and somatic mutations (G38A, P88S) of 
connexin40 (Cx40) have been identified within the atria of patients 
with a history of idiopathic atrial fibrillation (AF).10 
Immunohistochemistry for Cx40 on atrial tissue from patients with 
somatic mutations revealed a mosaic pattern of abnormal gap 
junction expression and intracellular accumulation. Furthermore, 
immunofluorescence of transfected N2A cells revealed that the 
germ-line mutation, while appearing to form normal gap junctions, 
caused abnormal intracellular accumulation of Cx40. N2A cells 
transfected with each of the three mutants were found to have 
markedly reduced gap junction conductances when compared to 
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wild-type connexin40. In addition, co-transfection of wild-type 
connexin40 (wtCx40) and connexin43 (Cx43) along with either 
P88S or A96S into oocytes revealed a dominant negative effect of 
each mutant on gap junctional conductance. The results 
suggested that each mutant was pathogenic. Interpretation of the 
results of these functional studies are however limited. Firstly gap 
junction naïve cell lines were used to assess each mutation. A 
variety of studies have demonstrated that connexins are subject to 
a variety of post translational modifications, something that is 
likely dependant on the cell type used. This may explain why the 
same lab has since demonstrated conflicting conductance 
alterations between N2A cells and oocytes during the assessment 
of a somatic Cx43 mutation. Hence connexins should idealy be 
studied within their native context, that is within cardiomyocytes. 
Secondly, the validity of the oocyte voltage clamping studies has 
been questioned given the presence of large variations in baseline 
conductances of Cx40 only transfected controls. In particular, 
while the amount of wtCx40 cRNA injected into each oocyte was 
kept constant, mean conductance of coupled oocytes between 
experiments varied by approximately 20μS. Finally, dual whole 
cell studies fail to consider the modulating effects of extracellular 
signals found within a myocyte syncytium. Hence we aimed to 
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characterise the phenotype of primary cardiomyocyte cultures 
following somatic gene transfer of Cx40 mutations. We 
hypothesised that if pathogenic, each Cx40 mutant should result 
in conduction slowing.  
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4.2 Methods 
4.2.1 Vector packaging and titration 
Vector stocks encoding eGFP, wild-type Cx40, and the three 
mutant connexin40’s P88S, G38A, and A96S were produced 
using the four plasmid lipofection method as described in section 
2.3.1 to 2.3.3. Titre was assigned to vector stocks by assessing 
genomic DNA integration of viral DNA following transduction of 
HEK293T cells as described in sections 2.3.4.1 to 2.3.4.3.   
4.2.2 Myocyte isolation, transduction and culture 
Neonatal rat ventricular myocytes were isolated from 2 to 3 day 
old Sprague Dawley rat pups as described in sections 2.2.3. After 
each isolation, cardiomyocytes were separated into a maximum of 
6 study groups using 50 ml polypropylene tubes as shown in 
figure 4.1. Vector transduction of cardiomyocytes in suspension at 
equal multiplicities of infection was performed in the presence of 
Polybrene 8μg/mL as described in section 2.3.5. The non-
transduced group received Polybrene 8μg/mL without viral vector. 
Following transduction, cardiomyocytes were seeded at a density 
of 220 x 103 cells/cm2 onto polystyrene plates for immunoblotting, 
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4 well chamber slides (Nunc) for immunofluorescence and 
polyimide multi-electrode arrays for the assessment of 
cardiomyocyte electrophysiology. 
4.2.3 Multi-electrode array studies 
Transduced eGFP control monolayers were initially assessed for 
their level of transduction. If transduction efficiency was lower than 
95% in any culture, all cultures within the experiment were 
discarded and section 4.2.2 repeated.  
Following placement in the MEA stage, culture wells were sealed 
with the stimulation electrode apparatus and the culture 
temperature maintained at 37°C for a minimum of 5 minutes prior 
to further assessment. If the beat frequency of an individual 
culture was greater than 2Hz, the culture was discarded. 
Conduction velocity assessment was performed as described in 
sections 2.8.1 to 2.8.3. In brief, cultures were stimulated at a 
frequency of 2 Hz with square shaped 30μA current pulses of 1ms 
duration.  
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Figure 4.1: NRVM study flow diagram. 
Following isolation from rat pups, NRVM’s were separated into 6 
groups and transduced in suspension (except for the non-
transduced group). Cultures were analysed 96 hours post plating. 
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Monolayer capture was assessed with recording of monolayer 
field potentials via the multi-electrode array system shown in 
figure 3.2. The software CEPAS was then used to generate 
isochronal maps of each culture and calculate the velocity of far 
field potential propagation. 
4.2.5 Immunoblotting 
Myocytes were collected for protein extraction and quantification 
at approximately 96 hours post plating as described in section 
2.6.2 and 2.6.3. Once prepared, protein samples underwent 
immunoblotting as described in section 2.6.3. In brief, samples 
were subject to electrophoretic separation on 4-12% Bis-Tris 
gradient gels, followed by membrane transfer using the iBlot gel 
transfer system. Membranes were washed and incubated with 
primary antibodies for either Cx40 or Cx43, followed by secondary 
incubation. The chemiluminescence system was used to produce 
immunoblot images of the probed protein bands. 
4.2.6 Immunofluorescence 
Co-immunostaining was commenced at approximately 96 hours 
post plating as outlined in section 2.4.3. Chamber slides were 
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gently washed, fixed with 4% (w/v) paraformaldehyde, 
permeabilised with 0.05% (v/v) Triton X-100, and blocked with 
goat serum. Slides were co-incubated with primary antibodies for 
Cx40 and Cx43, followed by co-incubation with secondary 
antibodies for the respective rabbit and mouse primary antibodies. 
Slides were cover slip mounted with the aid of Prolong Gold anti-
fade reagent containing the DAPI nuclear stain. Fluorescent 
images were acquired using an Olympus FV 1000 confocal laser 
scanning microscope as detailed in section 2.4.4. 
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4.3 Results 
Table 4.1 summarises the results of Cx43 and Cx40 expression 
within each study group along with their effect on conduction 
velocity. Both the NT and eGFP groups possessed similar 
membranous Cx43 levels and lacked membranous Cx40. 
Conduction velocity was mildly reduced within the eGFP group. 
While the wtCX40 and A96S groups possessed similar 
membranous Cx43 to that of the NT group, there was also 
membranous Cx40 expression. Compared to the NT group, 
conduction velocity was moderately reduced within the wtCX40 
group and greatly reduced within the A96S group. Membranous 
expression of Cx43 within the P88S group was reduced compared 
to the NT group, and almost absent within the G38A group. 
Membranous Cx40 was absent within the P88S group and sparse 
within the G38A group. Conduction velocity was moderately 
reduced within the P88S group. There was no capture of G38A 
cultures on stimulation. 
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4.3.1 Isochronal maps and conduction velocities 
Isochronal maps, which represent the distance travelled by a 
propagating action potential wave front over fixed consecutive 
time intervals, were generated for each monolayer. Figure 4.2 
demonstrates representative isochronal maps from each of the 6 
study groups (n = 6 within each group). In cultures with a slower 
than usual conduction velocity, less distance is travelled during 
consecutive isochrones and hence isochronal narrowing or 
crowding is observed. The opposite is observed in monolayers 
with faster than usual conduction velocities where isochrones are 
wider due to the greater distance travelled during a fixed time 
interval. Isochrones within the non-transduced map are generally 
equal and the mean conduction velocity for the group is 20.1 ± 1.8 
cm/s. Compared to non-transduced cultures, the eGFP group 
possessed mildly narrower isochrones and this translated to a 
mildly slower mean group conduction velocity of 18.3 ± 2.1 cm/s. 
Compared to the non-transduced monolayers, the wtCX40 group 
possessed a significantly slower mean group conduction velocity 
of 14.1 ± 1.2 cm/s (p < 0.05). Isochrones were markedly crowded 
within the A96S mutant group (Figure 4.2), translating to a 
significantly slower group mean conduction velocity of 8.4 ± 2.1 
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cm/s when compared to wtCx40 monolayers (p < 0.05) as shown 
in Figure 4.3. Interestingly, the P88S mutant group had almost 
similar spaced isochrones compared to the wtCX40 group and a 
mean group conduction velocity of 13.8 ± 1.6 cm/s. All G38A 
mutant transduced cultures possessed spontaneous fibrillatory 
type myocyte contractile activity and were not capturable with 
stimulation even after escalating the current amplitude slowly up 
to a maximum of 1mA and pulse duration up to 2ms. 
4.3.2 Immunofluorescence and immunoblotting 
Only wtCX40 and A96S monolayers expressed abundant 
membranous Cx40 (red signal) as shown in the confocal images 
of co-immunostained monolayers in figure 4.4. Membranous 
expression of Cx40 within the G38A group was sparse and within 
the P88S group absent. Intracellular Cx40 expression was evident 
within P88S monolayers. While the wtCX40 and A96S groups 
contained similar levels of membranous Cx43 expression, 
monolayers expressing P88S and G38A possessed markedly 
reduced membranous Cx43 expression with almost complete 
abolishment in the latter. Areas of possible membranous 
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Figure 4.3: Graphical representation of conduction velocities. 
A bar graph of the mean conduction velocity of each transduction 
group. Conduction velocities within the A96S group are clearly 
slower compared to the wtCX40 group.  
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Figure 4.4: Co-Immunostaining of NRVM cultures.  
Co-immunostaining for Cx40 (red) and Cx43 (green) in NT and 
eGFP, wtCX40, P88S, G38A and A96S transduced cultures. 
Yellow signal identifies areas of possible co-localisation of Cx40 
and Cx43. Nuclei labelled blue with DAPI. 
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Figure 4.5: Immunoblots for connexin 40 expression in 
NRVM’s. 
Immunoblots and densitometry for Cx40 normalised to ß-tubulin 
and expressed relative to the non-transduced group. Cx40 over 
expression is seen within NRVM’s from each group (n = 1 for 
each group). 
ß-tubulin 
 
Cx40 
 
Group NT eGFP wtCx40 A96S G38A P88S 
Densitometry 1 0.73 3.56 4.15 3.87 1.7 
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Figure 4.6: Immunoblots for connexin 43 expression in 
NRVM’s. 
Immunoblots and densitometry for Cx43 normalised to ß-tubulin 
and expressed relative to the non-transduced group. Significantly 
reduced Cx43 expression is seen within NRVM’s from the G38A 
group when compared to the wtCX40 group (p < 0.05; n = 3 for all 
groups). 
ß-tubulin 
 
Cx43 
 
Group       NT      eGFP wtCx40 A96S P88S G38A 
Densitometry   1 0.66 ± 0.36 
1.06 
±  0.17 
0.69 
± 0.43 
0.85 
±  0.27 
0.26 
± 0.06 
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co-localisation of Cx40 and Cx43 within wtCX40 and A96S 
monolayers were evidenced by yellow signal. Immunoblotting 
confirmed significant Cx40 expression within wtCx40 and mutant 
Cx40 transduced cardiomyocytes as shown in figure 4.5. 
Furthermore, immunoblotting for Cx43 revealed an almost 
complete absence within the G38A group as shown in figure 4.6. 
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4.4 Discussion 
Our results have for the first time confirmed that a significant 
electrophysiological functional impairment is imparted to 
cardiomyocytes by the Cx40 mutations G38A, and A96S. The 
results have also provided an insight into the mechanism by which 
all three investigated Cx40 mutations may be pathogenic.  
4.4.1 Characteristics of wild-type Connexin40 
The co-localisation appearance of wtCX40 with native Cx43 at the 
cell membrane suggests that the formation heteromeric 
connexons is responsible for the conduction slowing observed 
within wtCX40 transduced cultures. These findings are consistent 
with previous NRVM optical mapping studies which demonstrated 
that wtCX40 transduction resulted in conduction slowing whilst co-
expression of wtCX40 with a Cx43 siRNA knockdown vector 
increased conduction velocities.87 
162 
 
4.4.2 Characteristics of the G38A Connexin40 
Mutation 
The sparse membranous expression of Cx40 in G38A monolayers 
means that the formation of heteromeric heterotypic channels with 
reduced conductances is an unlikely explanation for the 
conduction impairment observed. Instead, myocyte uncoupling 
itself due to an almost complete absence of membranous Cx43 is 
the likely cause for the fibrillatory contractile activity of G38A 
transduced monolayers. The reduction in membranous Cx43 is 
paralleled by a reduction in total cellular Cx43 indicating that the 
G38A mutant interferes with the production process and/or 
intracellular trafficking of Cx43. 
4.4.3 Characteristics of the A96S Connexin40 
Mutation 
Given that the A96S mutant expresses at the cell membrane and 
appears to co-localise with membranous Cx43 on fluorescent 
microscopy, conduction slowing is likely mediated through the 
formation of heterotypic heteromeric channels. The greater 
degree of conduction slowing compared to wtCx40 indicates that 
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the A96S mutation may either have a dominant negative effect on 
Cx43 function or alter the ratio of Cx40 to Cx43 within gap 
junctions.  
4.4.4 Characteristics of the P88S Connexin40 
Mutation 
Although our studies revealed similar impairments of conduction 
velocities between monolayers transduced with either wtCx40 or 
P88S when compared to eGFP controls, the mechanisms by 
which this is achieved is clearly different. WtCx40 depends on the 
development of heteromeric heterotypic channels while P88S 
likely depends on Cx43 knock down to achieve conduction 
slowing. The lack of conduction velocity differences between 
P88S and wtCx40 in combination with the immunofluorescence 
studies demonstrates a lack of sensitivity of the MEA system 
when differing mechanisms of conduction slowing are present. 
4.4.5 Other considerations 
Sodium and potassium channels, both of which contribute to the 
cardiac action potential, have been shown to co-localise with 
164 
 
Cx43 at the intercalated discs.88, 89 Voltage clamping studies of 
Cx43-null neonatal myocytes have revealed no differences in 
action potential characteristics when compared to wild-type 
myocytes.90, 91 Hence the membranous reduction in Cx43 
observed within P88S and G38A monolayers is unlikely to have 
had an effect on the expression of sodium and potassium 
channels within these groups. The occurrence and significance of 
sodium and potassium channel co-localisation with Cx40 is 
unknown however. Hence an alteration in sodium and potassium 
channel expression may still be possible within all three Cx40 
mutant groups. Nevertheless, if alterations in sodium and 
potassium channel expression were to have occurred to different 
degrees within each monolayer group, this would be further 
support of a pathogenic role for these mutations. 
Neonatal rat ventricular myocytes undergo further differentiation 
during the process of isolation and culture. In addition to an in 
vitro environment, this differentiation process lacks the electrical, 
mechanical, and humoral regulatory factors found within an in vivo 
environment.  Although action potential characteristics between 
cultured neonatal myocytes and intact cardiac myocytes are 
similar, gap junction distribution is diffuse and immature within 
165 
 
neonatal myocyte cultures.92 Hence in vivo confirmation of the 
functional impairment imparted to intact cardiomyocytes by the 
Cx40 mutations and their propensity to induce arrhythmia is still 
required.  
Despite the limitations of neonatal myocyte cultures, the results 
further demonstrate that the MEA system in combination with 
immunofluorescence can be a useful screening tool for assessing 
the functional significance of mutations prior to embarking on 
more costly and labour intensive in vivo investigations.  
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CHAPTER 5 
 
In Vivo Somatic Atrial Gene Transfer of Human 
Connexin40 Mutations Increases the Propensity 
for Arrhythmia 
 
5.1 Introduction and aims 
We previously demonstrated that the connexin40 (Cx40) 
mutations A96S and G38A alter the electrophysiological 
properties of cardiomyocytes. While the use of neonatal 
cardiomyocyte cultures demonstrated a reduction in endogenous 
connexin43 (Cx43) expression following P88S transduction, there 
was a failure of the multi-electrode array system to discriminate 
conduction slowing due to myocyte uncoupling from that of 
heterotypic heteromeric channel formation hypothesized to occur 
with wild-type Cx40 (wtCX40) transduced cultures.  
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Furthermore, the altered differentiation process of neonatal 
myocytes compared to intact tissue may have altered the impact 
that each mutation had on cellular electrophysiology. Hence in 
vivo confirmation of the functional impairment imparted to intact 
cardiomyocytes by the Cx40 mutations and their propensity to 
induce arrhythmia is needed. 
In vivo models have been used extensively to elucidate the roles 
of connexins in electrical conduction and atrial fibrillation (AF). 
Results have been difficult to interpret due to the inherent 
limitations of the models used. Genetically engineered models are 
plagued by congenital malformations, while human biopsy studies 
suffer from the lack of appropriate disease state controls. A 
“chicken and egg” scenario exists with AF induced animal models. 
In particular, does the induction process directly change connexin 
expression to precipitate AF, or are the observed changes in 
connexin expression due the occurrence of AF.  
More recently, two studies have utilised a gene therapy approach 
to assess the role of connexins in AF. Utilising adenoviral 
mediated gene transfer both studies were able to demonstrate a 
reduced vulnerability to AF after Cx43 overexpression.62, 63  
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Hence we aimed to characterise the phenotype of rat hearts 
following expression of the Cx40 mutations by somatic gene 
transfer. We hypothesised that if pathogenic, each Cx40 mutant 
should result in conduction slowing and increase the propensity 
for atrial arrhythmia.  
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5.2 Methods 
A total of 5 study groups were used as shown in Figure 5.1. The 
first 2 groups were transduced to express either eGFP or wtCX40 
while the last three were transduced to express A96S, P88S, or 
G38A. Each group used a total of 6 adult Sprague Dawley rats.  
Studies were performed as outlined in Figure 5.2. 
5.2.1 Vector packaging and titration 
Vector stocks encoding eGFP, wtCx40, and the three mutant 
connexin40’s P88S, G38A, and A96S were produced using the 
four plasmid lipofection method as described in sections 2.3.1 to 
2.3.3. Titre was assigned to vector stocks by assessing genomic 
DNA integration of viral DNA following transduction of HEK293T 
cells as described in sections 2.3.4.1 to 2.3.4.3.   
5.2.2 Left atrial transduction 
Left atrial transduction was performed as described in sections 
2.9.4 and 2.3.6. In brief, rats were anesthetized with 2% 
isoflurane, and the left atrium exposed via a left thoracotomy. 
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Figure 5.2: In vivo study protocol 
All rats underwent a baseline electrophysiology study (EPS) 
followed by left atrial transduction. EPS was re-performed at day 7 
followed by removal of the left atrium. Atria were probed for Cx40 
and Cx43 protein levels, Cx43 mRNA levels, and inflammation 
and fibrosis with histological analysis. 
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A transduction gel mix consisting of 108 lentivector genomes, 20% 
(wt/vol) Pluronic F127, 0.5% (wt/vol) Trypsin, and polybrene 
(160μg/mL) was applied to the left atrium and allowed to adsorb 
for 20 minutes prior to closure of the thoracotomy. 
5.2.3 Electrophysiology studies 
Electrophysiology studies were performed as described in section 
2.9.1, 2.9.2, and 2.9.3. In brief, recordings were made using 
subcutaneous needle electrodes while stimulation was performed 
with trans-oesophageal pacing. Stimulation used both 
programmed stimulation and atrial burst pacing. Programmed 
stimulation used an 8 beat drive train with a coupling interval of 
150ms followed by 1 extra-stimulus down to refractoriness. Burst 
pacing used a coupling interval of 90ms for a duration of 5s.  
5.2.4 Morphometric studies 
All rats were weighed prior to each electrophysiology study. In 
addition, hearts were extracted and weighed before dissecting off 
the left atria. 
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5.2.5 Immunoblotting 
Left atria were excised and stored following day 7 
electrophysiology studies as described in section 2.9.5. Protein 
was extracted from atria and quantified as described in sections 
2.6.2 and 2.6.3. Once prepared, protein samples underwent 
immunoblotting as described in section 2.6.3. In brief, samples 
were subjected to electrophoretic separation in 4-12% Bis-Tris 
gradient gels, followed by membrane transfer using the iBlot 
(Invitrogen) gel transfer system. Membranes were washed and 
incubated with primary antibodies for either Cx40 or Cx43, 
followed by secondary incubation. The chemiluminescence 
system was used to produce immunoblot images of the probed 
protein bands. 
5.2.6 Immunofluorescence 
Left atria were excised and stored following day 7 
electrophysiology studies as described in section 2.9.5. Atria were 
then cryostat sectioned and subjected to immunostaining as 
described in section 2.4. In brief, sections were gently washed, 
fixed with 4% (w/v) paraformaldehyde, permeabilised with 0.05% 
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(v/v) Triton X-100, and blocked with goat serum. Slides were 
incubated with primary antibodies to either Cx40 or Cx43, followed 
by incubation with their respective secondary antibodies. Slides 
were cover slip mounted with the aid of Prolong Gold anti-fade 
reagent containing the DAPI nuclear stain. Fluorescent images 
were acquired using either a Leica DMIL wide field fluorescent 
microscope or an Olympus FV 1000 confocal laser scanning 
microscope. 
5.2.7 Haematoxylin and Eosin staining 
Fresh atrial tissue sections were produced as described in section 
2.4.2. Haematoxylin and eosin staining was performed as 
described in section 2.5.1. Following image acquisition as 
described in section 2.5.3, images were blindly assessed for the 
level of inflammation by two independent observers. The scoring 
system used to grade inflammation is as follows. 1 - absent, 2 - 
occasionally present, 3 - ≤ 50% affected, 4 – 50% to 90% 
affected, 5 - ≥ 90% presence. 
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5.2.8 Picro-Sirius Red staining 
Picro-Sirius red staining of atrial tissue was performed as 
described in section 2.5.2. Following image acquisition as 
described in section 2.5.3, images were processed (as shown in 
figure 5.3) with custom made software designed to objectively 
identify the total pixel area occupied by collagen (red) and the 
total pixel area occupied by the remaining tissue (green). The ratio 
of the area of collagen to the area of collagen plus remaining 
tissue was used to calculate the percentage fibrosis within each 
image. 
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5.3 Results 
There were no significant differences in heart weight, body weight, 
and heart weight to body weight ratios between eGFP and wtCx40 
groups (shown in Table 5.1). In addition, there was no significant 
difference in all three parameters between mutant Cx40 and 
wtCx40 groups.  
5.3.1 Electrophysiology studies 
Electrophysiology studies revealed a significant prolongation of P 
wave duration in the A96S, G38A, and P88S groups compared to 
the wtCx40 group as shown in Figure 5.4. In addition, P wave 
prolongation was associated with bifid P wave formation. The P 
wave duration was similar between the non-transduced, eGFP, 
and wtCx40 groups. Figure 5.5 demonstrates that both sinus 
rhythm and AF following burst pacing can be clearly distinguished. 
The duration of induced AF was significantly prolonged within all 3 
mutant Cx40 groups when compared to the wtCx40 group as 
shown in Figure 5.6. There was no significant difference in AF 
duration between non-transduced, eGFP, and wtCx40 groups. 
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Figure 5.6: Mean durations of atrial fibrillation 
A) Mean durations of AF within each group. B) Bar graph of mean 
durations of induced AF showing significantly longer durations in 
the A96S, G38A, and P88S groups when compared to the wtCx40 
group (*p<0.01). 
A) 
Baseline eGFP wtCx40 A96S G38A P88S 
0.6 ± 1.2 0.6 ± 1.3 0 4.2 ± 3.14* 3.3 ± 1.7* 9.9 ± 17.9* 
 
B) 
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5.3.2 Immunofluorescence 
Immunofluorescence for Cx40 revealed membranous expression 
within the wtCx40 and A96S groups as shown in Figure 5.7. 
Membranous Cx40 expression was however absent within the 
P88S and G38A groups. Non-transduced and eGFP transduced 
hearts did not express membranous Cx40. 
Immunofluorescence for Cx43 revealed a marked reduction in 
membranous expression within the G38A and P88S groups when 
compared to the wtCx40 group as shown in Figure 5.8. Similar 
levels of membranous expression were observed between the 
non-transduced, eGFP, wtCx40, and A96S groups.  
5.3.3 Immunoblotting 
Immunoblotting of tissue lysates revealed increased Cx40 within 
left atria transduced to express wild-type or mutant Cx40 as 
shown in Figure 5.9. Quantitative densitometry revealed a greater 
level of expression within the wtCx40 and mutant groups 
compared to non-transduced and eGFP groups. Immunoblotting 
of tissue lysates also revealed increased Cx43 expression within  
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Figure 5.9: Immunoblots for left atrial Cx40 expression 
Immunoblots and densitometry for Cx40 normalised to ß-tubulin 
and expressed relative to the non-transduced group. Cx40 over 
expression is seen within left atria of groups transduced to 
express a wild-type or a mutant Cx40 (n = 1 for each group). 
ß-tubulin 
 
Cx40 
 
Group  NT eGFP wtCx40 A96S G38A P88S 
Densitometry  - 0.72 4.21 6.50 3.06 1.29 
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Figure 5.10: Immunoblots for left atrial Cx43 expression. 
Immunoblots and densitometry for Cx43 normalised to ß-tubulin 
and expressed relative to the non-transduced group. Significantly 
increased Cx43 expression is seen within left atria from the P88S 
group when compared to the wtCx40 group (p < 0.05; n = 3 for all 
groups). 
ß-tubulin 
 
Cx43 
 
Group     NT eGFP wtCx40 A96S G38A P88S 
Densitometry     - 1.18 ± 0.32 
0.95 
± 0.19 
1.38 
± 0.38 
0.94 
± 0.49 
2.19 
± 0.63 
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Figure 5.11: Quantitative PCR for Cx43 mRNA. 
Cx43 mRNA levels normalised to GAPDH mRNA within atrial 
tissue for each study group. There was no significant difference in 
each of the mutant groups when compared to the wtCx40 group. 
(n=3 for all groups) 
 
NT eGFP wtCx40 A96S G38A P88S 
0.92 ± 
0.07 
0.82 ± 
0.06 
0.82 ± 
0.11 
1.01 ± 
0.28 
0.89 ± 
0.30 
0.84 ± 
0.05 
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the P88S group when compared to the wtCx40 transduced group 
as shown in Figure 5.10. Cx43 levels were similar between the 
G38A and wtCx40 groups. 
5.3.4 Connexin43 mRNA 
There was no significant difference in the left atrial Cx43 mRNA 
levels of each mutant Cx40 group when compared to the wtCx40 
group as shown in Figure 5.11. 
5.3.4 Inflammation and fibrosis 
Inflammation scores of left atrial sections stained with 
haematoxylin and eosin were similar between wild-type and all 
mutant Cx40 groups as shown in Figure 5.12. Furthermore, there 
was no significant difference in levels of fibrosis between wild-type 
and mutant Cx40 groups as shown in Figure 5.13. 
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5.4 Discussion 
For the first time, we have clearly demonstrated the pathogenicity 
of the Cx40 mutations A96S, G38A, and P88S within an in vivo 
model. In addition to precipitating conduction slowing, all three 
mutations also result in an increased propensity for AF.  
5.4.1 In vivo characteristics of A96S, P88S, and G38A 
Given the consistency of our immunofluorescence studies 
between atrial tissue and neonatal cardiomyocyte cultures, the 
mutations P88S and G38A likely exert their effects by reducing 
native Cx43 myocyte coupling while the mutation A96S likely co-
localises with connexin43 in gap junction channels to mediate 
conduction slowing.  
The observed parameters of left atrial conduction slowing (P wave 
prolongation and bifid morphology) caused by A96S, P88S, and 
G38A within the left atrium are consistent with the results from our 
primary cardiomyocyte cultures. Such findings are also commonly 
seen in patients with left atrial enlargement. While 
echocardiographic or MRI assessment for left atrial enlargement 
in our rats was not performed, the absence of significant 
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inflammatory and fibrotic changes between wild-type and mutant 
Cx40 groups in combination with conduction slowing on our MEA 
studies makes this possibility unlikely.  
Interestingly immunoblotting detected no change in overall cellular 
levels of Cx43 within the G38A group and an increase within the 
P88S group. This was surprising given the reduction in observed 
membranous expression of Cx43 and the lack of increased 
intracellular expression with immunofluorescence. In addition, 
Cx43 mRNA levels were similar between all study groups. It is 
likely that Cx40 and Cx43 share the same intracellular machinery 
for production. Hence P88S and G38A may be inducing 
conformational changes within Cx43. Such changes may cause 
steric hindrance, rendering the epitope inaccessible to our anti-
Cx43 antibody on immunofluorescence. The denaturation process 
involved with sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE), which utilises a detergent, heat, 
and reducing agent, may remove this inaccessibility.93 
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5.4.2 In vivo characteristics of wild-type connexin40 
The lack of left atrial conduction slowing and resistance to AF 
induction following wtCx40 transduction was unexpected, 
particularly given the demonstration of conduction slowing within 
primary cardiomyocyte cultures. The in vivo results of wtCx40 are 
however consistent with a recent study that transduced porcine 
atria with wtCx40.63 In that study, wtCx40 reduced the vulnerability 
of porcine atria to pacing induced AF. The mechanism behind the 
reduced vulnerability of atria to AF following Cx40 gene transfer is 
unclear. One possibility is that wild-type Cx40 fails to form 
heterotypic heteromeric channels in vivo, an effect that may speed 
up conduction. Alternatively, the level of transduction achieved 
within our study may not have been high enough to result in 
significant conduction slowing from the formation of heterotypic 
heteromeric channels. Hence the presence of a Cx40 mutation 
(such as A96S) with a negative dominant effect on Cx43 function 
is also required to tip the balance towards conduction slowing. 
Other possible mechanisms include alterations in the 
phosphorylation status of both Cx40 and Cx43 and alterations in 
the availability of sodium channels. 
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5.4.3 Other considerations 
Sodium channels, which contribute to the cardiac action potential, 
have been shown to co-localise with Cx43 at the intercalated 
discs.88, 89 The occurrence and significance of sodium channel co-
localisation with Cx40 is unknown however. While Cx43-null 
cardiomyocytes possess similar action potential characteristics to 
wild-type cardiomyocytes, the effects of Cx40 alterations have not 
been studied.90, 91 Hence an alteration in sodium channel 
expression may also contribute to some of the conduction slowing 
observed. Nevertheless, alterations in sodium channel expression 
would not act to exclude each mutant as pathogenic.  
The transgenes used within this study utilised a lentivector to 
facilitate transduction and a tissue non-specific CMV promoter to 
drive expression. Hence non-cardiomyocytes (predominately 
fibroblasts), which constitute more than 50% of the cells in an 
adult rat heart, would have expressed Cx40.94, 95 Although no 
evidence exists for fibroblast-myocyte coupling within the native 
heart outside of the sino-atrial node, transduced fibroblasts may 
have coupled with transduced cardiomyocytes within the setting of 
our study and modulated myocyte action potential propagation.96, 
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97 The indirect in vivo findings of conduction slowing (longer P 
wave durations) within the atria for each of the studied Cx40 
groups were however consistent with our in vitro studies making 
this possibility less likely. 
5.4.4 Implications of somatic mutations 
Familial AF is considered a monogenic disorder with an 
autosomal dominant pattern of inheritance. Non-familial AF 
however, which represents the majority of cases of AF, is 
considered primarily a polygenic disorder.98, 99 The existence of 
functional somatic mutations however provides an alternative 
explanation for the otherwise lack of identification of causative 
mutations in the setting of non-familial AF. Further support for a 
possible larger role of somatic mechanisms in the generation of 
atrial arrhythmias is the existence of electrical rotors or focal 
drivers of AF identified in most patients with AF.100 It is quite 
possible that the substrates supporting these rotors are secondary 
to localised areas of somatic mutation. 
Given the mosaic nature of expression of somatic mutations within 
the atria, no technique currently exists that could conclusively 
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diagnose a somatic mutation as a precipitant for AF within a 
patient. This is of particular concern as we enter into the era of 
human cardiac gene therapy.101 
The rescue of porcine atrial myocardium from pacing induced AF 
after over expression of wild-type Cx43 in combination with an 
absence of detrimental ventricular arrhythmias, suggests that a 
“blanket” approach of Cx43 up regulation in all patients with 
idiopathic AF may be a possible therapeutic strategy. This would 
bypass the need for confirming the presence of a somatic 
mutation in patients with AF. Studies with a large animal model, 
and a more clinically relevant viral vector such as an adeno-
associated virus, is however required to further assess the 
therapeutic and safety profile of this approach. 
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CHAPTER 6 
Summary and General Discussion 
With an aging population and an increasing prevalence of atrial 
fibrillation (AF), an imperative exists to elucidate the mechanisms 
underpinning arrhythmogenesis. The ability of connexins to 
influence cardiac conduction has long been recognised as 
described within section 1.2. Results of studies into the roles 
connexin isotypes and mutations play in cardiac conduction and 
arrhythmogenesis have however been conflicting, largely owing to 
the models used for study. The technique of somatic gene transfer 
presented itself as a unique method for overcoming some of the 
technical limitations of these models. To date, only 3 other studies 
have utilised somatic gene transfer techniques in an attempt to 
understand the functional significance of connexins, each with 
their own limitations.62, 63, 102 The contents of this thesis in this 
regard, describe an innovative approach for using such 
techniques to understand the role of connexin mutations in atrial 
physiology and AF. 
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6.1 In Vitro Ion Channel Screening Systems 
6.1.1 Summary 
Tissue conduction velocity is determined by drivers and resistors 
to action potential conduction. The main drivers of conduction 
include the action potential amplitude and speed of action 
potential generation (determined by fast sodium channels) while 
the main resistors are intracellular cytoplasmic resistance and 
intercellular resistance (determined by the quantity and functional 
characteristics of connexons located at gap junctions). 
Traditionally, studies into the role of ion channel mutations in 
cardiac diseases have utilised voltage clamping techniques 
(single or dual cell) or cell culture mapping10, 55, 103, 104 Voltage 
clamping techniques fail to consider the modulating extracellular 
effects of a multicellular system. Cell culture studies have used 
cells from genetically engineered animal models and thus are 
likely subject to some of the confounding effects and limitations.  
The validation of somatic gene transfer techniques combined with 
the multi-electrode array (MEA) system within this thesis (Chapter 
3) shows that this technique can be used to assess ion channels 
that affect both action potential characteristics and intercellular 
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communication. This novel and fundamental work provides a 
sound basis upon which this technology can be further applied to 
the functional characterisation of the rapidly accumulating list of 
identified ion channel mutations. With the advent of inexpensive 
printable circuit board (PCB) technology for MEA production105 
and induced pluripotent stem cell (IPS) technologies106, 
successful clinical transition of this work has the potential to 
provide a personalised diagnostic service.107 
6.1.2 Limitations 
6.1.2.1 Measurement of cellular electrical activity 
The methodological limitations of this study system, while not 
detracting from the strength of the central observation of 
conduction velocity, do constrain complete assessment of cellular 
electrical activity. In particular, far field potentials represent an 
indirect gross spatiotemporal measurement of surrounding cellular 
action potentials. Hence while changes in far field potentials 
resemble alterations in a patient’s surface electrocardiogram 
(such as QT duration), they are less sensitive compared to the 
cellular action potential.107 Hence complete characterisation of ion 
channel function in the setting of a mutation is best performed with 
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patch clamping techniques until higher resolution technologies 
can be validated.  
6.1.2.2 NRVM cellular electrophysiology 
It is well established that gap junction distribution is diffuse and 
immature within neonatal rat ventricular myocyte (NRVM) 
cultures.92 In addition, NRVM’s undergo further differentiation 
during isolation and culture, a process that lacks the electrical, 
mechanical, and humoral regulatory factors found within an in vivo 
environment. Hence although being cardiomyocytes, the NRVM 
ion channel expression profile is likely neither that of a mature 
atrial or ventricular myocyte. Consequently there are bound to be 
false positive and false negative results when compared to mature 
myocytes in an in vivo setting. 
6.1.2.3 Protein interactions and toxicity 
It is clear that NRVM’s are highly sensitive to non-physiological 
manipulations and require gentle and careful processing. While 
lentivirus has been shown to not adversely affect NRVM function 
for up to at least 10 days, function is sensitive to the type of 
protein overexpressed.83, 85 Hence careful optimisation is required 
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for each type of ion channel before mutational screening can be 
performed.  
6.1.3 Future Directions 
6.1.3.1 MEA technology 
With the advent of printable circuit board technology, the cost of 
manufacturing an MEA has dropped to less than a dollar 
(Australian). As a result, it is now feasible to produce MEA chips 
customised for the purpose of high throughput mutational 
screening. Although electrode size, number, and density are 
confined in part by resolution limitations of conventional PCB 
technology, advances have been made in the adaptation of other 
electronic technologies such as complementary metal–oxide–
semiconductor (CMOS) chips for the purpose of MEA studies. 
With a spatiotemporal resolution in excess of 4000 electrodes 
within an approximate area of 7mm2, the electrophysiological data 
that stands to be gleaned is immense.108  
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6.1.3.2 Cellular technologies 
Cardiomyocytes produced from induced pluripotent stem (IPS) 
cells have shown great promise for personalised medicine, with 
their successful use for medication optimisation in patients with 
channelopathies. From a mutational screening point of view, they 
provide the perfect context for ion channel study on an MEA, and 
in the setting of germline mutations obviate the need for viral 
vectors.107 Unfortunately at this point in time, IPS technology is 
within its infancy and a great deal remains to be elucidated about 
the differentiation pathways involved before high throughput 
screening can be performed. 
  
203 
 
6.2 Connexin Mutations and Conduction 
6.2.1 Summary 
Fibrillatory conduction within the atrium occurs when a re-entrant 
circuit of very short cycle length drives tissue faster than which 1:1 
conduction can occur.109 Re-entrant circuits require the presence 
of unidirectional block and alterations in conduction velocity.110 
Both connexin40 (Cx40) and connexin43 (Cx43) have been 
shown to modulate conduction velocity as described in section 
1.2. The novel mutant Cx40 studies of Chapter 4 show that when 
each mutant is co-expressed with endogenous Cx43, they 
modulate conduction velocity in a manner different to that of wild-
type Cx40.  
Using an acute somatic gene transfer technique, the Cx40 
mutants A96S, P88S, and G38A were characterised as loss of 
function mutants with slowing of conduction in MEA studies. The 
loss of function imparted to gap junctions differed mechanistically 
between each mutant.  
The ramifications of these results are 2 fold. Firstly they provide 
an insight into how ‘real world’ germline and somatic mutations 
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might give rise to substrate supportive of AF. Secondly they 
highlight the mutational screening benefit of the MEA system in a 
‘real world’ scenario. 
6.2.2 Limitations 
6.2.2.1 Somatic mutations and in vitro implications 
The majority of mutations identified within the various 
channelopathies have an autosomal dominant pattern of 
inheritance.111 In this setting, the combination of in vitro 
confirmation of channel impairment, phenotype/genotype 
correlations, and co-segregation studies are sufficient to confirm 
any given mutation as pathogenic. Given the focal nature of 
cardiac somatic mutations however, phenotype/genotype 
correlations are more difficult, requiring prior electrophysiological 
mapping of re-entrant circuits (rotors) within the atria. 
Furthermore, co-segregation studies are not possible. Hence the 
loss of function demonstrated with the P88S and G38A somatic 
Cx40 mutations while significant, does not have the corroborative 
support of genotype/phenotype correlations and co-segregation 
studies to implicate them as the definitive cause of AF within the 
patients in which they were identified.  
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6.2.2.2 Germline mutations and in vitro implications 
Traditional voltage clamping studies of germline mutations in ion 
channels responsible for action potential generation often reveal a 
gain or loss of function that can be directly correlated with ECG 
characteristics such as QT prolongation or shortening. In vitro 
studies of the germline mutation A96S while revealing reduced 
gap junction conductance10 and alterations in conduction velocity 
cannot be directly correlated with the phenotype of AF. A 
phenotype suggestive of atrial conduction slowing however, 
namely P wave prolongation, was identified in the patient with an 
A96S mutation and his 2 sons, both of whom also carried the 
mutation.10 A more extensive familial screen was not mentioned to 
comment on definite co-segregation of this finding. Both sons 
were not afflicted with AF. The A96S allele was also identified 
within 1 out of 170 asymptomatic controls giving a population 
allele frequency of 0.3%. Although high when compared to 
mutations responsible for channelopathies such as long QT 
syndrome (>0.04%), the allele frequency was not helpful given the 
small sample size of the control group and the higher population 
prevalence of AF compared to other channelopathies. 
Furthermore, the relatively young (48 year old) control carrier 
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could go on to develop AF as they age. The Exome Variant 
Server Database for population allele frequencies did not contain 
data regarding the A96S Cx40 allele at the time of writing this 
thesis.112  
6.2.3 Future Directions 
Bearing in mind the interpretative limitations of in vitro studies, in 
vivo studies are required to determine whether the functional 
impairment imparted to gap junctions by mutations is able to 
create a substrate supportive of AF. Acute somatic gene transfer 
using a direct topical approach for viral delivery to a small rodent 
heart would be the ideal in vivo model. Such a model would 
circumvent the congenital limitations associated with genetically 
engineered models. Furthermore, a topical approach for viral 
delivery to the atria would minimise the potential for lethal 
ventricular arrhythmias due to ventricular transduction. Other 
advantages of a small animal model include the need for only 
small quantities of virus for transduction, ease of manipulation and 
handling, and convenience of housing and animal care.  
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6.3 Connexin Mutations and Arrhythmia 
6.3.1 Summary 
Review of the anatomy of the atrium reveals 4 specialised 
conduction paths (inter-atrial tract, internodal tracts - anterior, 
middle, and posterior) for rapid impulse propagation from the SA 
node to the left atrium and AV node.113 It would be expected then 
that should atrial activation originate from an ectopic re-entrant 
focus of short cycle length (such as one possibly caused by a 
somatic connexin mutation), the atria would have a reduced ability 
to conduct in a 1:1 manner and hence an increased vulnerability 
for AF. If conduction slowing is also impaired by a germline 
connexin mutation, then complex patterns of atrial activation with 
more severe conduction block might also be expected in the 
setting of an ectopic re-entrant focus. Of note, Bagwe and co-
workers demonstrated complex atrial activation with conduction 
block during a relatively slow ectopic atrial rhythm in Langendorff-
perfused Cx40 knock-out hearts, an effect that resolved with 
ablation of the ectopic foci (section 1.2.2.1). 
We previously demonstrated that the Cx40 somatic mutations 
A96S, P88S, and G38A imparted a loss of function to gap 
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junctions with conduction slowing in NRVM cultures. Within 
Chapter 5, we have gone on to show that gap junction loss of 
function is capable of producing a tissue substrate that is 
supportive of AF. Using acute somatic gene transfer to the left 
atrium via a topical route of administration, we demonstrated an 
increased propensity for inducible AF following atrial transduction 
with each of the Cx40 mutations.  
The ramifications of these findings are four fold: firstly they 
confirm a role for connexins in the pathogenesis of idiopathic AF, 
secondly they strengthen the evidence for somatic mutations in 
general as a cause for idiopathic AF, thirdly they represent the 
first in vivo non-genetically engineered genotype-phenotype 
correlations ever performed for a mutation identified in a patient 
with AF, and lastly they raise the possibility of a wider role of 
somatic mutations in the generation of all types of cardiac 
arrhythmias. 
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6.3.2 Limitations 
6.3.2.1 Mechanisms: From cells to arrhythmia 
The mechanism behind which conduction slowing causes AF in 
the setting of acute gene transfer to a rat atrium remains to be 
elucidated. Whether AF induction was a result of an inability of the 
left atrium to conduct in a 1 to 1 fashion from our stimulation 
protocol or whether transduction has given rise to a re-entrant 
circuit via an area of mosaic expression is not known. In addition, 
the rat myocardium is clearly different from humans with respect 
to size, ECG characteristics, and ion channel expression. Hence 
results that may be significant within a rat heart may not 
necessarily be so within a human heart. Lastly, non-specific 
cellular transduction was performed within rat atria. Hence 
transduced non-myocytes may have played a role in modulating 
impulse propagation and altered the propensity for AF.  
6.3.3. Future Directions 
Given the inherent limitations of Chapter 5, further evaluation 
within a large animal model is required. Acute somatic gene 
transfer should be performed both focally and globally throughout 
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the atria to understand how both focal somatic mutations and 
diffuse germline mutations may give rise to AF. With a larger sized 
heart, it becomes possible to map the atrium using standard 
electrophysiological techniques as used in humans. In addition, 
the impact of radiofrequency ablation would be readily 
assessable. Finally, assessment of the therapeutic benefits of 
mutant allele knockdown and/or overexpression of either Cx40 or 
Cx43 is needed prior to moving to therapeutic clinical trials. 
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6.4 Connexin Mutations and Atrial Arrhythmia – Final 
Comments  
The clinically relevant studies hereto described within this thesis 
provide the first glimpses into the role somatic mutations may play 
within the intact heart. In addition to confirming the findings of 
previous studies (section 1.2) with respect to the ability of 
connexins to modulate impulse propagation, they also represent 
the first ever in vivo non-genetically engineered genotype-
phenotype correlations for AF.  
Large animal models using similar somatic gene transfer 
techniques, clinically relevant targeted viral vectors, and 
electrophysiological mapping are now required to better 
understand the mechanisms behind which impairment of 
conduction precipitates AF and to determine the best strategy for 
a genetic cure. Armed with such information, a rational targeted 
approach to human therapy becomes feasible, particularly as we 
move into an era of gene therapy. 
Lastly, as IPS cell and organ generation technologies progress, it 
will become feasible to apply the techniques used within this 
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thesis directly to human cells and tissue, bypassing the need for 
animal studies. 
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